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ABSTRACT 
The Tat-interactive protein of 60 kDa (Tip60) is a histone acetyltransferase enzyme that 
appears to have a wide range of acetylation targets, which include core histone proteins H2A and 
H4, transcription factors Myc and p53, the androgen receptor, and ATM kinase.  Additionally, 
Tip60 appears to play a role in several cellular processes such as transcriptional regulation, DNA 
damage repair, chromatin remodeling, and apoptosis.  Due to its diverse roles, the deregulation 
of Tip60 has been implicated in several human diseases, including Alzheimer’s disease and some 
cancers.  Several studies have been conducted in an attempt to elucidate the regulation of Tip60’s 
acetyltransferase activity.  Studies have suggested that the binding of Tip60’s chromodomain to 
methylated lysine residues found on histone tails is important for targeting substrates and 
allosterically regulating the enzyme.  This research aimed to determine the structure of the 
chromodomain, identify its binding partners, and elucidate the mechanism of binding.  
Ultimately, the research aimed to clarify how binding of the chromodomain to its partners would 
affect acetyltransferase activity.  Through x-ray crystallography, the crystal structure of the 
Drosophila melanogaster Tip60 chromodomain was solved to a resolution of 1.59 Å.  The 
binding partners of the chromodomain were revealed through the use of surface plasmon 
resonance and confirmed by isothermal titration calorimetry.  The binding studies found that the 
chromodomain preferentially bound peptides, which corresponded to modifications found on the 
histone H4 N-terminal tail. 
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1 INTRODUCTION 
The DNA molecule is the building block of all living organisms.  It provides instructions 
for the growth, development, and function of everything within an organism.  Within eukaryotes, 
DNA is often condensed and coiled around histone proteins to form the fundamental unit of 
chromatin: the nucleosome.  The organization and compaction of chromatin often poses a 
challenge to cellular replication, transcription, and repair machinery, which requires access to 
DNA.  This problem is often solved through the use of post-translational modifications on histone 
proteins to alter their affinity for DNA.  The addition of post-translational modifications is 
typically carried out by histone modifying enzymes, such as histone acetyltransferases.  
Additionally, the loss or deregulation of histone modifying enzymes is often implicated in human 
disease.  Therefore, understanding the roles and mechanisms of a histone modifying enzyme’s 
function and activity is an important step in identifying their role in human disease. 
The histone acetyltransferase Tat-interactive protein of 60 kDa (Tip60) was found to 
possess a wide range of acetylation targets, which include core histone proteins, transcription 
factors, the androgen receptor, and ATM kinase.  The diverse amount of acetylation targets also 
indicated that Tip60 is involved in numerous cellular processes, such as transcriptional 
regulation, DNA damage repair, chromatin remodeling, and apoptosis.  It comes as no surprise 
that, due to Tip60’s diverse roles, the deregulation of the protein is often implicated in several 
human diseases.  Therefore, understanding how Tip60 is regulated and how it functions is an 
important step in understanding its role in human disease. 
There have already been several studies conducted, which attempt to elucidate the 
regulation of Tip60’s acetyltransferase activity.  These studies suggest that the binding of the 
Tip60 chromodomain to methylated lysine residues found on histone tails is important for 
targeting substrates and allosterically regulating the enzyme.  The structural basis of binding of 
the Tip60 chromodomain to methylated lysine residues and, subsequently, the allosteric 
regulation of its acetyltransferase are currently unknown.  Previous studies on the Tip60 
chromodomain have suggested that, based on a sequence alignment with the canonical 
methyllysine binding chromodomain of HP1α, the mechanism for binding methyllysine is 
achieved through the use of an aromatic cage.  However, the Tip60 chromodomain shows poor 
sequence identity with the chromodomain of HP1α.  Additionally, other closely related 
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chromodomains to Tip60, such as essential Sas2-related acetyltransferase 1 (Esa1) and males-
absent on the first (MOF), show an absence of an aromatic cage.  This casts doubt onto the data 
published in these prior studies of the Tip60 chromodomain.  Unpublished data from the Moore 
lab has shown that the MOF chromodomain interacts with histone H4 tail peptides.  Based on the 
sequence conservation between the Tip60 chromodomain and the closely related MOF 
chromodomain, and the unpublished data regarding the MOF chromodomain, we hypothesize 
that the Tip60 chromodomain will bind methyllysine found on histone H4 tails. 
The research objectives aim to determine the structure of the Tip60 chromodomain 
through X-ray crystallography and elucidate the binding partners of the chromodomain through 
in vitro binding studies.  Structure determination of the Tip60 chromodomain will utilize the 
chromodomains from the Homo sapiens Tip60 splice variant Tip60β and the Drosophila 
melanogaster Tip60 enzymes.  This study also aims to identify and characterize the binding 
partners of the Tip60 chromodomain through in vitro binding studies, which include nuclear 
magnetic resonance (NMR), surface plasmon resonance (SPR), and isothermal titration 
calorimetry (ITC).  Once the structure and binding partners of the chromodomain have been 
identified, we hope to determine the structural basis of binding through X-ray crystallography, 
NMR, and mutagenesis studies.  Ultimately, this study aims to elucidate the mechanism for the 
allosteric regulation of the histone acetyltransferase (HAT) domain by the binding of the 
chromodomain to its targets. 
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2 LITERATURE REVIEW 
2.1 Chromatin Packaging and Remodeling 
2.1.1 Nucleosome Structure and Regulation 
The genomic DNA of eukaryotes was found to be wrapped around an octamer of core 
histone proteins H2A, H2B, H3, and H4 to form the fundamental unit of chromatin: the 
nucleosome (Soria et al., 2012).  Approximately 145-147 base pairs of DNA are wrapped around 
the histone core 1.65 times in a left-handed superhelix (Figure 2.1) (Luger et al., 1997).  Each of 
the four core histone proteins are composed of two distinct domains: the histone tail and the 
histone fold, each of which have different functions (Andrews and Luger, 2011).  A detailed look 
at the nucleosome core particle revealed that each histone protein possess a flexible N-terminal 
tail and that histone H2A also possess a flexible C-terminal tail (McGinty and Tan, 2015).  The 
histone fold region of all core histones was also found to contain three α helices connected by 
two loops in an α1-L1-α2-L2-α3 configuration (Figure 2.2) (McGinty and Tan, 2015).  The fold 
region in each of the core histones was found to contain a high level of structural similarity 
(Andrews and Luger, 2011). 
 
Figure 2.1 Overview of the nucleosome core particle crystal structure.  The nucleosome core 
particle from Xenpus laevis (PDB ID 1KX5) solved to 1.9 Å by Davey et al., 2002.  The double 
strand DNA (orange) is shown wrapped around an octamer of core histone proteins H2A 
(yellow), H2B (magenta), H3 (blue), and H4 (green). 
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Figure 2.2 Structure and schematics of the core histone proteins.  The crystal structure of the 
histone proteins from Xenopus laevis (PDB ID: 1KX5) was solved to 1.9 Å by Davey et al., 2002.  
All four core histones are composed of a histone fold region, which contains an α1-L1-α2-L2-α3 
motif.  The histone extensions are shown for each histone protein in a different shade as compared 
to the histone fold motif.  Each histone has an N-terminal tail extending from the histone fold and 
histones H2A and H2B contain a C-terminal tail as well.  Figure adapted from McGinty and Tan, 
2015. 
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Within the nucleosome core particle, the histone octamer is subdivided into four dimer 
pairs consisting of two H3-H4 pairs and two H2A-H2B pairs (Figure 2.3).  These heterodimers 
are formed by complimentary histone folds interacting with one another.  The antiparallel 
configuration of the heterodimer results in the L1 loop of one histone packing against the L2 loop 
of the complimentary histone (McGinty and Tan, 2015).  The heterodimers have a crescent 
shaped appearance, which results in a convex surface that contains the L1L2 loops and the α1 
helices, and creates a concave surface which contains the α2 and α3 helices (McGinty and Tan, 
2015).  This convex surface was found to carry a strong positive charge, which allows it to 
function as the primary DNA binding surface for each heterodimer (McGinty and Tan, 2015).  
To form the nucleosome, the two pairs of H3-H4 dimers form a tetramer through the interaction 
of a 4-helix bundle, formed between the α2 and α3 helices from the histone folds of H3 and H3’ 
(Figure 2.4A) (Luger et al., 1997).  The H2A-H2B dimers were found to interact with the H3-H4 
tetramer through a similar 4-helix bundle, formed between the α2 and α3 helices from the histone 
folds of H2B and H4 (Figure 2.4B) (Luger et al., 1997).  The two H2A-H2B dimers were found 
to only have limited interactions with one another (Andrews and Luger, 2011). 
 
 
 
Figure 2.3 Crystal structure of the core histone heterodimers.  The crystal structure of the histone 
fold region of the histone proteins from Xenopus laevis (PDB ID: 1KX5).  The heterodimers are 
formed through the interaction of complimentary histone folds.  The antiparallel configuration 
results in the L1 loop of one histone packing against the L2 loop of the complimentary histone.  
A. H2A-H2B dimer.  B. H3-H4 dimer.  Figure adapted from McGinty and Tan, 2015. 
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Figure 2.4 Four helix bundles found in the histone octamer.  An overview of where these bundles 
are located in the nucleosome is shown on the left and a magnified view of the bundles is shown 
on the right.  All structures are from Xenopus laevis (PDB ID: 1XK5).  A. The H3-H4 dimers 
form a tetramer through a four helix bundle, which is formed by the α2 and α3 helices of the 
histone folds of histone H3 and H3’ (shown in blue).  B. The H2A-H2B dimers complete the 
octamer by forming a similar four helix bundle composed of the α2 and α3 helices of histones 
H2B (magenta) and H4 (green).  To differentiate the αC helix from the α3 helix in histone H2B, 
the αC helix has been coloured light pink. 
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In addition to the four canonical core histone proteins, it was found that core histones 
H2A, H2B, and H3 possess different isoforms (referred to as histone variants) than those 
previously described (Venkatesh and Workman, 2015).  Currently, no additional isoforms have 
been identified for histone H4 (Maze et al., 2014).  Histone variants have been found to be coded 
by different genes than those which code for the canonical histone proteins; it was found that the 
variants were highly conserved between different species (Luger et al., 2012).  The histone 
variants were found to differ from the canonical histones, either by a few amino acids or through 
the presence of additional domains (Venkatesh and Workman, 2015).  Histone variants were 
found to be involved in the replacement of missing histones or transcribed specifically during the 
S-phase of the cell cycle to ensure high expression levels (Luger et al., 2012; Venkatesh and 
Workman, 2015).  The exchange of canonical histones with variants was found to result in the 
alteration of chromatin structure and dynamics, by affecting protein-protein interactions and post-
translational modifications of histones (Maze et al., 2014; Venkatesh and Workman, 2015). 
The DNA in the nucleosome core particle was found to interact directly with the histone 
octamer.  Approximately 121 base pairs of DNA interact with the histone fold regions of each of 
the four dimers (Davey et al., 2002).  This equates to approximately 27-28 base pairs of DNA 
interacting with each dimer and 4 base pairs of DNA to link each region (Luger et al., 1997).  The 
remaining 13 base pairs, located at each end of the DNA, were found to bind the αN helices at 
the N-terminus of each of the two H3 histones (Luger et al., 1997).  The binding of the DNA to 
the histone folds is predominantly facilitated by hydrogen bonding between the histone folds and 
the phosphodiester backbone of DNA (Luger et al., 1997).  Furthermore, it was also found that 
the interactions between the histones and DNA were also facilitated through water mediated 
hydrogen bonds (Davey et al., 2002).  While the majority of interactions occur through direct or 
water mediated hydrogen bonding between the histone and the phosphodiester backbone of DNA, 
it was found that approximately 20 side chains bind the DNA in the minor groove (Davey et al., 
2002).  Additionally, it was found that the histone-DNA interaction was also mediated by ionic 
and non polar interactions (McGinty and Tan, 2015). 
As the fundamental unit of chromatin, each nucleosome particle was found to be linked 
together by short segments of DNA, termed linker DNA, approximately 20-50 base pairs in 
length (Segal and Widom, 2009).  The length of the linker region between each nucleosome core 
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particle was found to vary, depending on the cell type and species (Struhl and Segal, 2013).  The 
linked nucleosome core particles form the 10 nm nucleosome fibre, which is often considered the 
first level of chromatin compaction and organization (Li and Reinberg, 2011).  The primary 
mechanism for the formation of the 30 nm chromatin fibre was thought to be the interaction 
between the N-terminal tail of histone H4 and the acidic patch found on the canonical histone 
H2A (Tremethick, 2007).  This interaction was found to be integral to forming the 30 nm fibre, 
as the deletion of the H4 tail or the replacement of canonical histone H2A with its variant 
H2A.Bbd, which features a truncated acidic patch, resulted in the inability to form the 30 nm 
fibre (Tremethick, 2007).  Additionally, the presence of linker histones, such as H1 or H5, are 
thought to aid in the formation of the 30 nm chromatin fibres (Luger and Hansen, 2005; Segal 
and Widom, 2009).  Finally, the 30 nm chromatin fibres are thought to undergo further 
condensation to form the highly ordered chromatin fibres (Luger et al., 2012).  An overview of 
chromatin structure and compaction is shown in Figure 2.5. 
 
Figure 2.5 Overview of chromatin structure and compaction.  The nucleosome is formed by the 
DNA (orange) wrapping around the core histone proteins (blue discs).  Nucleosomes are then 
linked together by linker DNA to form the 10 nm fibre.  The addition of linker histones (e.g. H1 
or H5) and other scaffold proteins (yellow triangles), which interact with the nucleosomes, leads 
to the formation of the 30 nm fibre and high order chromatin fibres.  Figure adapted from Luger 
et al., 2012. 
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The highly ordered nature of chromatin organization and compaction can act as a barrier 
for the replication, transcription, and repair of DNA (Marmorstein and Trievel, 2009).  There 
have been studies which have sought to determine the mechanism by which chromatin condenses 
and compacts.  These studies have found that the mechanism by which the 30 nm chromatin fibre 
was constructed involved an acidic patch on canonical histone H2A and the N-terminal tail of 
histone H4, and that these components were integral to the fibre’s formation (Tremethick, 2007).  
Therefore, alterations to these histones in the form of histone H2A variants and/or post-
translational modifications to the H4 tail aid in the relaxation of the chromatin fibres (Luger et 
al., 2012).  The post-translational modification of histones and chromatin remodeling allows for 
the cellular machinery involved with replication, transcription, and repair to access the 
chromosomal DNA (Fischle, 2009). 
2.1.2 Post-Translational Modifications of Histone Tails 
The ability for cellular machinery to access DNA for replication, transcription, and repair 
is a vital cellular process.  However, the highly ordered nature of chromatin organization and 
compaction serves as a barrier to the machinery to access the DNA.  It was found that the structure 
and dynamics of chromatin could be regulated by the post-translational modifications (PTMs) of 
histone proteins (Musselman et al., 2012).  These modifications allow for the cellular machinery 
to access the DNA to perform necessary functions, such as replication, transcription, and DNA 
repair (Fischle, 2009).  The process by which PTMs exert regulatory effects on chromatin 
structure and dynamics was found to be through two distinct methods.  The first method of 
regulation was found to be through the direct disruption of histone interactions with other histones 
or DNA (Kouzarides, 2007).  The second method of regulation by PTMs was through the 
recruitment of effector proteins or complexes (Musselman et al., 2012).  Additionally, it was 
found that a wide variety of histone PTMs exist to regulate different functions; these PTMs 
include, but are not limited to, acetylation, methylation, phosphorylation, ubiquitination, 
sumoylation, ADP ribosylation, deimination, and proline isomerization (Table 2.1) (Kouzarides, 
2007).  It should be noted that intracellular signals govern the time, location, and type of PTMs 
observed, and thus not all modifications will be present at once (Kouzarides, 2007). 
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Table 2.1 Overview of histone modifications and the functions regulated. Table adapted from 
Kouzarides, 2007. 
Modification Type Residues Modified Regulated Functions 
Acetylation Lysine Transcription, repair, replication, 
condensation 
ADP ribosylation Glutamate Transcription 
Deimination Arginine Transcription 
Methylation Lysine 
Arginine 
Transcription, repair 
Transcription 
Phosphorylation Serine 
Threonine 
Transcription, repair, condensation 
Transcription, repair, condensation 
Proline Isomerization Proline Transcription 
Sumoylation Lysine Transcription 
Ubiquitination Lysine Transcription, repair 
The post-translational modifications, which possess the ability to directly disrupt 
interactions with other histones or DNA, must occur on the histones at locations that are relatively 
accessible for the modifying enzymes.  As a result, the majority of PTMs identified on histones 
were found on the N-terminal tails (Kouzarides, 2007).  Additionally, studies which removed the 
N-terminal histone tails found that the nucleosomes were unable to compact into the 30 nm 
chromatin fibres (Suganuma and Workman, 2011; Tremethick, 2007).  This indicated that 
modifications made to histone tails could directly affect inter-nucleosome contacts (Suganuma 
and Workman, 2011).  In addition to modifications on the histone tails, it was identified by mass 
spectrometry that PTMs were also present on the globular domains of the core histone proteins 
(Freitas et al., 2004).  Several of these PTMs were found to occur along the lateral surface of the 
core histones and, subsequently, many of these modified residues were found to be involved with 
interacting DNA (Cosgrove et al., 2004).  The lateral surface was found to be positively charged 
to facilitate binding to the negatively charged DNA backbone and, therefore, it was proposed that 
PTMs, which altered the charge of the lateral surface (e.g. acetylation and phosphorylation), 
could cause significant disruption to the interaction with DNA (Tropberger and Schneider, 2013). 
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In addition to the direct disruption of interactions, PTMs have been found to exert 
regulatory effects through the recruitment of effector proteins and complexes (Musselman et al., 
2012).  These effector proteins and complexes typically possess histone binding domains, which 
recognize and bind only specific histone modifications (Campos and Reinberg, 2009).  The 
recruitment of these effector proteins may result in the crosslinking of nucleosomes, the increased 
occupancy of the RNA polymerase complex, the recruitment of chromatin remodelers, or the 
recruitment of other chromatin modifying enzymes (Ruthenburg et al., 2007).  There are many 
examples of PTMs recruiting effector proteins and complexes to exert a regulatory effect.   
As previously mentioned, there are a wide variety of histone modifications, which 
include, but are not limited to: acetylation, methylation, phosphorylation, ubiquitination, 
sumoylation, ADP ribosylation, citrullination, and proline isomerization (Kouzarides, 2007).  
Each modification possesses different properties, such as net charge and size, which can influence 
how it exerts its regulatory effects.  For example, the acetylation of a lysine residue located on 
the histone H3 or H4 tail was proposed to neutralize the positive charge exhibited by the lysine 
residue and, subsequently, weaken its interaction with DNA (Zentner and Henikoff, 2013).  
Another example of PTMs that utilize charge manipulation to exert regulatory effects are the 
phosphorylation of serines, threonines, and tyrosines found on the N-terminal tails of histones 
(Bannister and Kouzarides, 2011).  It has been proposed that the phosphorylation of histones 
could impart a negative charge on its modified residue, resulting in charge repulsion between the 
negatively charged phosphodiester backbone of DNA and the phosphorylated histone residue 
(Zentner and Henikoff, 2013).  Additionally, the phosphorylation of histones has been implicated 
in the alteration of chromatin binding domains affinity for their targets.  This has been observed 
with the phosphorylation of serine 10 on histone H3 (H3S10Ph), causing the release of the 
chromatin binding protein HP1 from the adjacent tri-methylated lysine nine on histone H3 
(H3K9Me3) (Zentner and Henikoff, 2013). 
One of the more complex modifications found on histones is the methylation of lysine 
and arginine residues.  The methylation of histones does not impart a charge to its modified 
residue; therefore, it exerts its regulatory effects in much less direct manner than charge 
manipulation (Zentner and Henikoff, 2013).  Furthermore, histone methylation has been found 
to be much more complex, in that lysine residues can be mono-, di-, or tri-methylated on the ε-
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amino group, and the arginine residues can be mono-methylated, symmetrically di-methylated, 
or asymmetrically di-methylated on the Ω-nitrogen, where each methylation state can correspond 
to a different regulatory outcome (Musselman et al., 2012).  For example, the mono-methylation 
of lysine 20 on histone H4 is associated with active gene transcription, whereas the tri-
methylation of lysine 20 was associated with heterochromatin and gene repression (Barski et al., 
2007).  A brief summary of the common modifications to the lysine residues located on the 
histone H3 and H4 N-terminal tails relevant to this research is shown in Figure 2.6. 
Due to the diverse amount of histone modifications and the ability of the modifications to 
regulate different functions, it was required that there be an equally diverse amount of histone 
modifying enzymes and readers of their subsequent PTMs.  These readers of PTMs are integral 
to the recruitment of the appropriate cellular machinery to chromatin, thus allowing a variety of 
cellular processes to be performed (Musselman et al., 2012).  Additionally, the misreading and/or 
deregulation of PTMs have been implicated in human disease (Musselman et al., 2012).  The 
readers of PTMs can be grouped into categories, depending on the modification with which they 
recognize.  Some examples of PTM readers include methyllysine, methylarginine, acetyllysine, 
phosphoserine, and phosphothreonine readers (Musselman et al., 2012; Taverna et al., 2007).  
Table 2.2 outlines a few examples of specific PTM readers and their target modifications.  This 
literature review will examine the chromodomain methyllysine reader in more detail in section 
2.2. 
As previously mentioned, to accommodate and regulate the wide variety of PTMs, there 
is an equally diverse amount of histone modifying enzymes.  These enzymes serve to deposit or 
remove modifications on the histone residues.  Examples of histone modifying enzymes include 
histone acetyltransferases (HATs), histone deacetylases (HDACs), lysine or arginine 
methyltransferases, serine/threonine kinases, ubiquitinases, and lysine demethylases 
(Kouzarides, 2007).  It was reported that methyltransferases and kinases were the most specific 
of the modifying enzymes, as members of these two classes often only target one specific histone 
residue (Kouzarides, 2007).  This literature review will only examine the histone 
acetyltransferase class of histone modifying enzymes. 
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Table 2.2 Histone readers and the targeted modification 
Modification Recognized PTM Reader Specific Histone PTM Recognized 
Methyllysine Chromodomain H3K9Me3, H3K27Me3, H3K4Me1, 
H4K20Me1 
MBT H3KMe1, H3KMe2, H4KMe1, H4KMe2 
PHD H3K9Me3, H3K4Me2, H3K4Me3 
Tudor H3K36Me3 
Acetyllysine Bromodomain H3KAc, H4KAc, H2AKAc, H2BKAc 
Methylarginine Tudor H3RMe2, H4RMe2 
WD40 H3R2Me2 
Phosphoserine/threonine 14-3-3 H3S10Ph, H3S28Ph 
BIR H3T3Ph 
Unmodified Histone PHD H3N 
WD40 H3N 
Figure 2.6 Summary of commonly modified lysine residues on the N-terminal tails of histone H3 
and H4.  The nucleosome core particle from X. laevis (PDB ID 1KX5) is shown on the left panel.  
The N-terminal tails of histone H3 (blue extension) and histone H4 (green extension) are circled 
in red.  The right panel shows the N-terminal tail sequence of histones H3 and H4 from H. 
sapiens.  The lysine residues are coloured red and their corresponding modification is listed 
below. 
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2.2 The Chromodomain – A Reader of Post-Translational Modifications 
The complexity of lysine methylation on histones (i.e. mono-, di-, or tri-methylation) 
results in numerous different methyllysine readers, capable of differentiating the lysine’s 
methylation state.  Some examples of methyllysine readers include chromodomains, malignant 
brain tumour (MBT) domains, plant homeodomain (PHD) fingers, and Tudor domains 
(Musselman et al., 2012).  In general, methyllysine readers were found to utilize two to four 
aromatic residues positioned in a cage-like orientation to bind methylated lysine through a cation-
π interaction (Musselman et al., 2012).  This interaction involves the positively charged 
methylated lysine residue interacting with the partial negative charge from the quadrupole 
moment of an aromatic ring (Ma and Dougherty, 1997).  The cation-π interaction was found to 
be the predominant driving force in the interaction between methyllysine and the aromatic cage 
of the methyllysine reader (Hughes et al., 2007).  Additionally, it was found that hydrophobic 
and van der Waals interactions also contribute to the binding of methyllysine to its reader protein 
(Hughes et al., 2007). 
The methyllysine readers are often divided into two classes based on structural similarity: 
the Royal superfamily and the PHD finger family (Taverna et al., 2007).  The Royal superfamily 
consists of the chromodomain, chromo-barrel domain, MBT domain, the PWWP domain, and 
the Tudor domain (Musselman et al., 2012).  Some members of the Royal superfamily possess a 
β-sheet composed of three or four curved β-strands and an adjacent α-helix (Musselman et al., 
2012; Yap and Zhou, 2011).  The binding of the histone tail to the aforementioned members is 
thought to complete the β-barrel fold through the insertion of the histone tail between two of the 
existing β-strands (Figure 2.7A) (Taverna et al., 2007).  Other members of the Royal superfamily, 
such as the Tudor domains, possess a β-barrel composed of five β-strands (Musselman et al., 
2012).  In this case, the histone tails are unable to insert between the β-strands and instead lie 
along the edge of the β-barrel with the methyllysine situated in the aromatic cage (Figure 2.7B) 
(Musselman et al., 2012). 
As previously stated, chromodomains are a member of the Royal superfamily of 
methyllysine readers.  Typically, chromodomains are often divided into two major subgroups, 
canonical chromodomains and non-canonical chromodomains (Blus et al., 2011).  The canonical 
chromodomains are those which share high sequence identity and structural homology with the 
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HP1 chromodomain, whereas some non-canonical chromodomains adopt a similar fold to Tudor 
domains (Blus et al., 2011).  It should be noted, that other groups have further subdivided the 
non-canonical chromodomains into two additional groups: the chromodomain helicase-DNA 
binding subgroup and the chromo-barrel subgroup (Yap and Zhou, 2011).  Furthermore, it has 
been established that chromodomains typically bind methyllysine, however, it has been found 
that some chromodomains also interact with non-histone proteins and nucleic acids (Yap and 
Zhou, 2011).  Regardless of whether a chromodomain is classified as canonical or non-canonical, 
chromodomains are often found to be part of larger proteins or complexes with a variety of 
different functions (Blus et al., 2011).  Typically, the function of the chromodomain module is 
to target its associated protein or complex to methyllysine sites to facilitate regulatory effects 
(Yap and Zhou, 2011).  Chromodomains have been found in proteins such as methyltransferases, 
DNA helicases, and histone acetyltransferases (Blus et al., 2011). 
Figure 2.7 Overview of binding for members of the Royal Superfamily.  A. The crystal structure 
of the HP1 chromodomain (PDB ID: 1KNE) bound to H3K9Me3.  The histone tail peptide 
corresponding to H3K9Me3 (yellow) is shown inserted between β1 and β4 strands.  The tri-
methylated lysine is shown occupying the aromatic cage.  B. The crystal structure of the tandem 
Tudor domain 53BP1 (PDB ID: 2IG0) bound to H4K20Me2.  The histone tail peptide 
corresponding to H4K20Me2 (yellow) is shown to lie along the outer edge of the chromo-barrel 
(dark green) with the di-methylated lysine occupying the aromatic cage. 
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2.3 Histone Acetyltransferases 
2.3.1 Histone Acetyltransferase Families & Complexes 
One of the most well known and studied classes of histone modifying enzymes are the 
histone acetyltransferases (HATs).  These enzymes have been found to catalyze the acetylation 
of the core histone proteins to exert regulatory effects on chromatin structure and gene 
transcription (Lee and Workman, 2007).  There have been a large number of HATs identified 
across many different organisms, which are often organized into at least three distinct families 
based on the sequence conservation of the catalytic HAT domain (Marmorstein and Trievel, 
2009).  Within the catalytic region of the HAT domain it was found that only the acetyl coenzyme 
A (AcCoA) binding site motif was highly conserved across all HAT families (Roth et al., 2001).  
The regions, which flank the highly conserved AcCoA binding motif, were found to be very 
diverse and, therefore, it is the primary basis for assigning a specific HAT to one of the three 
distinct HAT families (Marmorstein and Trievel, 2009).  The three most well characterized HAT 
families include the GNAT (Gcn5 related N-acetyltransferase) family, the MYST (named after 
members MOZ, Ybf2/Sas3, Sas2, and Tip60) family, and the p300/CBP family (Carrozza et al., 
2003; Marmorstein and Trievel, 2009).  In this section, a brief overview of the multi-subunit HAT 
complexes and the three major HAT families are discussed.  The catalytic mechanism and 
substrate binding of HATs is discussed in detail in section 2.3.2. 
The majority of HATs have been found to be incorporated into larger multi-subunit 
complexes, which allow for the ability to acetylate free and nucleosomal histones (Carrozza et 
al., 2003).  These large multi-subunit complexes typically contained both enzymatic and non-
enzymatic subunits (Table 2.3) (Marmorstein, 2001).  It was found that these multi-subunit 
complexes were often more active than an individual catalytic subunit operating alone (Yang, 
2004).  Additionally, it was found that the non-enzymatic subunits could recruit substrates to the 
multi-subunit complexes (Yang, 2004).  This suggested that the composition of the different 
multi-subunit complexes regulated the enzymatic activity of the catalytic subunit, determined the 
substrate specificity, and subsequently allowed for the targeting of specific genes (Carrozza et 
al., 2003; Yang, 2004).  Furthermore, in regards to HATs, it was found that a HAT can be present 
in several distinct multi-subunit complexes (Yang, 2004). 
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The GNAT family of HATs were originally identified as aminoglycoside 
acetyltransferases (Vetting et al., 2005).  HATs have subsequently been found to be involved in 
the regulation of cellular growth and development, transcriptional activation, and DNA repair 
(Carrozza et al., 2003).  Some of the most well known members of the GNAT family include 
Gcn5, PCAF, Elp3, Hat1, Hpa2 and Nut1 (Lee and Workman, 2007).  The members of the GNAT 
family all share sequence and structural similarity to the Gcn5 acetyltransferase (Carrozza et al., 
2003).  Structural and sequence data of GNAT family members have revealed that members 
contain a GNAT fold, which is composed of six or seven anti-parallel β-strands and four α-helices 
arranged as shown in Figure 2.8A (Vetting et al., 2005).  Within the GNAT fold region, four 
conserved motifs have been identified and labeled A-D (appearing in the order C, D, A, B) (Wolf 
et al., 1998).  It was found that motif A is highly conserved and contains residues from the β4 
strand to the α3 helix, which are integral for AcCoA binding, motif B contains residues in the α4 
helix, which also contributes to AcCoA binding, motif D, which contains residues from β2 and 
β3 strands provides stability for the protein, and motif C was found to be located at the N-terminus 
of some GNAT family members (Srivastava et al., 2014).  Additionally, it was found that the 
GNAT fold possess a V-shaped opening between the β4 and β5 strands, which is important for 
AcCoA binding (Figure 2.8B) (Srivastava et al., 2014). 
Table 2.3 Subunits found in multi-subunit complexes 
Subunit Function 
Enzymatic Subunit 
Acetyltransferase Lysine acetylation 
Deacetylase Lysine deacetylation 
Methyltransferase Arginine and lysine methylation 
ATPase ATP-dependent nucleosome remodeling 
Kinase Serine phosphorylation 
Non-enzymatic Subunit 
Bromodomain Acetyllysine recognition 
Chromodomain Methyllysine recognition 
Zinc binding domain Protein recognition 
SANT domain DNA binding 
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As one of the largest families of HATs, the members of the MYST family have been 
found to be well conserved from yeast to humans and involved in a wide range of functions, 
which include DNA repair, gene regulation, and cell cycle regulation (Yuan et al., 2012).  Some 
of the most prominent members of the MYST family include Esa1, Sas2, Sas3, MOF, Tip60, 
MOZ, and HBO1 (Sapountzi and Cote, 2011).  All members of the MYST family share a highly 
conserved MYST domain, which is composed of an AcCoA binding motif, similar to the one 
found in the GNAT family of acetyltransferases, and a C2HC zinc finger (Utley and Cote, 2003).  
The MYST domain was found to be composed of 13 β-strands and seven α-helices (Figure 2.9A) 
(Yan et al., 2000).  Coenzyme A was found to bind between the α3 and α4 helices; a glutamate 
and cysteine residue in the active site were found to mediate substrate acetylation (Yan et al., 
2000; Yan et al., 2002).  Furthermore, it was found that the autoacetylation of an active site lysine 
Figure 2.8 Structural overview of the GNAT family.  A. Schematic of the GNAT fold, which is 
composed of 6 or 7 β-strands (yellow) and 4 α-helices (red).  B. Crystal structure of Gcn5 from 
Tetrahymena thermophila bound with acetyl-CoA (magenta) solved to 2.3 Å (PDB ID: 1PUA).  
AcCoA sits between the β4 and β5 strands and contacts the α3 and α4 helices.  Figure adapted 
from Srivastava et al., 2014. 
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was required for acetyltransferase activity (Yuan et al., 2012).  Outside of the highly conserved 
MYST domain, members of the MYST family have been found to possess additional conserved 
domains, such as a chromodomain, plant homeodomain (PHD) finger, or an additional zinc finger 
(Figure 2.9B) (Carrozza et al., 2003; Yang, 2004).  The MYST family can be divided into 
additional subgroups based on which of the aforementioned conserved domains is present 
(Carrozza et al., 2003).  These conserved domains serve specific functions, such as binding 
substrates or potentially regulating the catalytic activity of the HAT domain (Yang, 2004). 
The p300/CBP family of HATs was found to be present in many multicellular organisms 
ranging from worms to humans (Kalkhoven, 2004).  The two primary members p300 (protein of 
300 kDa) and CBP (CREB-binding protein) were originally found to bind adenoviral E1A and 
the cAMP response element binding protein (CREB) respectively (Chan and La Thangue, 2001).  
Since the initial discovery, it was found that p300 and CBP possessed HAT activity and that the 
HAT domains possessed greater than 90% sequence identity (Wang et al., 2008a).  Additionally, 
p300 and CBP possess many conserved functional domains, including three cysteine-histidine 
(CH) rich domains, a bromodomain, a KIX domain, and a nuclear coactivator binding domain 
(NCBD) (Figure 2.10) (Delvecchio et al., 2013).  These functional domains have been found to 
be involved in the interaction between p300/CBP with transcription factors, transcription 
machinery, and other coactivators (Delvecchio et al., 2013).  Additionally, studies have found 
that p300 and CBP are able to acetylate the four core histone proteins as well as 70-plus proteins 
(Wang et al., 2008a).   
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Figure 2.9 Overview of the MYST HAT family.  A. Structural overview of the conserved MYST 
domain from S. cerevisiae Esa1 (PDB ID: 3TO7).  A close up of the active site is shown in the 
left panel.  The residues required for acetyltransferase activity, which include an autoacetylated 
lysine, a glutamate, and a cysteine are shown in ball-and-stick representation (cyan).  CoA (green) 
is shown bound to the HAT domain.  B. Schematic overview of the MYST family.  The conserved 
MYST domain (red) contains the catalytic HAT domain and in most members also includes a 
Zinc finger (yellow).  Many members possess additional functional domains, such as a 
chromodomain (blue), PHD fingers (orange), or an additional zinc finger (dark blue).  Figure 
adapted from Carrozza et al., 2003. 
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2.3.2 Substrate Binding and Catalytic Mechanism 
Histone acetyltransferases are known to catalyze the acetylation of core histones by 
transferring the acetyl group from AcCoA to the ε-amino group of lysine residues found on the 
histone proteins (Roth et al., 2001).  The transfer of the acetyl group to the lysine residue 
neutralizes the positive charge of the lysine and disrupts the interaction with DNA and other 
chromatin binding proteins (Berndsen and Denu, 2008).  As previously discussed, HATs can be 
grouped into at least three distinct families, each of which have a preference for different 
substrates and potentially different catalytic mechanism (Marmorstein and Roth, 2001).  An 
overview of the how each family of HATs binds its substrate and the catalytic mechanism 
involved is discussed here. 
The members of GNAT family were found to utilize a ternary complex mechanism during 
catalysis (Hodawadekar and Marmorstein, 2007).  It was proposed that initially, before the start 
of catalysis, both the substrate and AcCoA bind the HAT domain (Berndsen and Denu, 2008).  
Following binding, a conserved glutamate residue deprotonates the ε-amino group of the target 
lysine.  This is immediately followed by the direct nucleophilic attack on the acetyl group of the 
bound AcCoA, which results in the acetylation of the target lysine (Figure 2.11) (Hodawadekar 
and Marmorstein, 2007). 
 
 
Figure 2.10 Schematic overview of the p300/CBP family.  Three cysteine-histidine rich regions 
(CH1, CH2, CH3) are found in p300.  There are four transactivation domains found in p300, 
which include: TAZ1 domain (orange), the CREB interacting KIX domain (pink), the CH3 region 
which incorporates the ZZ-type zinc finger (grey) and TAZ2 domain (cyan), and the NCBD 
domain (purple).  These transactivation domains serve to mediate interactions between p300 and 
other transcription factors.  The core of p300 is composed of a bromodomain (yellow), a RING 
domain (green), a PHD finger (red), and the catalytic HAT domain (blue).  Figure adapted from 
Delvecchio et al., 2013. 
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It was proposed that the MYST family of HATs utilized a different catalytic mechanism 
than the GNAT family.  Studies on the MYST family member essential Sas2-related 
acetyltransferase 1 (Esa1) from S. cerevisiae revealed that a ping-pong catalytic mechanism was 
employed (Yan et al., 2002).  However, a second study found that Esa1 utilized the ternary 
complex mechanism similar to the one employed by the GNAT family (Berndsen et al., 2007).  
One possible reason for this discrepancy is that both studies utilized different Esa1 constructs, 
where Yan et al. utilized a truncated version and Berndsen et al. utilized full length Esa1 and 
Esa1 complexed with two additional proteins, Epl1 and Yng2.  In the proposed ping-pong 
mechanism the HAT domain of the MYST protein binds AcCoA and the sulfhydryl group of a 
cysteine residue attacks the acetyl group of AcCoA, which yields an acetylated cysteine 
Figure 2.11 Proposed catalytic mechanism for the GNAT family.  Initially, AcCoA (red) and the 
lysine substrate typically from a histone protein (blue) bind the HAT domain at the active site 
(green).  The Glu residue from the HAT deprotonates the Lys substrate, which then attacks the 
carbonyl carbon of AcCoA and results in the acetylation of the Lys residue.  Figure adapted from 
Berndsen and Denu, 2008. 
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intermediate (Berndsen and Denu, 2008).  Once CoA was released, a lysine residue from the 
target substrate could bind the active site.  The lysine residue is then deprotonated by a glutamate 
residue, which in turn causes the lysine nucleophile to attack the acetylated cysteine (Figure 2.12) 
(Berndsen and Denu, 2008). 
 
Figure 2.12 Proposed ping-pong catalytic mechanism for the MYST HAT family.  Initially, the 
AcCoA (red) binds the HAT domain at the active site.  The sulfhydryl group of a Cys residue 
(green) within the active site attacks the acetyl group of AcCoA, which yields and acetylated-
Cys intermediary.  CoA leaves the active site and the lysine substrate, typically from a histone 
protein, enters the active site.  The Glu residue (green) in the active site deprotonates the Lys 
residue (blue), which subsequently attacks the acetylated Cys residue.  This results in the 
acetylation of the lysine substrate.  Figure adapted from Yan et al., 2002. 
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The p300/CBP family was proposed to possess another distinct mechanism for catalysis.  
It was proposed that based on the structure of the active site, the p300/CBP family utilized the 
unconventional Theorell-Chance catalytic mechanism (often nicknamed ‘hit-and-run’ 
mechanism), which does not produce a ternary complex (Liu et al., 2008).  In this mechanism it 
was proposed that AcCoA binds to the HAT domain first.  The positively charged lysine substrate 
then associates with the negatively charged P1 pocket of p300 and upon transfer of the acetyl 
group the substrate dissociates from the HAT domain (Wang et al., 2008a).  Furthermore, this 
proposed mechanism suggested that the indole side chain of a tryptophan residue guides the 
lysine substrate to attack AcCoA through van der Waals forces (Figure 2.13) (Liu et al., 2008). 
 
 
Figure 2.13 Proposed Theorell-Chance catalytic mechanism for the p300/CBP family.  Once 
AcCoA (red) binds to the active site, the positively charged substrate Lys (blue) associates with 
the HAT domain and attacks the acetyl group AcCoA.  Once the acetyl group has been 
transferred, the acetylated substrate dissociates from the active site.  The backbone carbonyl 
group of a Trp residue (green) in the active site was proposed to hydrogen bond with the Lys 
residue and the Trp indole side chain was expected to help guide the Lys residue towards 
attacking AcCoA.  Figure adapted from Liu et al., 2008. 
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2.4 Tip60, a Catalytic Subunit of the Tip60 HAT Complex 
2.4.1 Overview of Tip60’s Structure, Function, and Regulation 
The histone acetyltransferase human Tat-interactive protein of 60 kDa (Tip60) belongs to 
the MYST family of HATs (Sapountzi et al., 2006).  The HTATIP gene encodes the Tip60 protein 
and was found to contain 14 exons and express three splice variants of the protein: Tip60 isoform 
1, Tip60 isoform 2 (Tip60α), and Tip60 isoform 3 (Tip60β or phospholipase associated protein 
2 [PLA2] interacting protein, PLIP) (Sapountzi et al., 2006).  Each of the three isoforms of Tip60 
contained an N-terminal chromodomain, a C-terminal MYST domain, and a nuclear receptor-
interaction (NR) box at the extreme C-terminal end (Figure 2.14) (Sapountzi et al., 2006).  One 
study found that isoform 1 was the largest of the Tip60 splice variants as it incorporated intron 
1, which resulted in an extra 33 amino acids at the N-terminus of the protein (Legube and 
Trouche, 2003).  It has been speculated that this larger splice variant could exhibit functions 
distinct from the other two splice variants (Legube and Trouche, 2003).  The second isoform, 
Tip60α was found to be a 513 amino acid protein of 58 kDa and was the best characterized of the 
three isoforms (Sapountzi et al., 2006).  The third isoform, Tip60β excluded exon 5 which 
resulted in a 52 amino acid deletion between the chromodomain and the MYST domain 
(Sapountzi et al., 2006). 
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As previously discussed, most HATs were found to be part of larger multi-subunit 
complexes.  Tip60, for example, was found to be a part of the NuA4 HAT complex, which has 
been found to be evolutionarily conserved from yeast to humans (Squatrito et al., 2006).  The 
NuA4 complex in H. sapiens appeared to have the functionality of both HAT and chromatin 
remodeling complexes, whereas in yeast these functions were performed by two separate 
complexes, the NuA4 and SWR1 complexes respectively (Doyon and Cote, 2004).  The human 
NuA4 complex was composed of several subunits (Table 2.4), two of which contribute to its 
acetyltransferase and chromatin remodeling functions, Tip60 and p400/Domino respectively 
(Sapountzi et al., 2006; Squatrito et al., 2006).  Other subunits contained within the complex are 
important for NuA4’s function and stability; these subunits include: the 
transformation/transcription domain-associated protein (TRAAP), which acts as a scaffold and 
was found to be essential to the stability of the complex; a 53 kDa BRG-1/human BRM-
associated factor (BAF53), which has an actin-related domain that may be involved in histone 
chaperone activity; the inhibitor of growth 3 (ING3) subunit contained plant homeodomain 
(PHD) fingers and was also found to be involved in the transcription of p53 as well as playing a 
role in apoptosis and DNA damage signaling; the mortality factor 4 related gene 15 (MRG15) 
subunit contained a chromodomain and was involved in the regulation of cell viability, 
Figure 2.14 Schematic representation of the three isoforms of Tip60 found in H. sapiens.  Each 
isoform contained a N-terminus chromodomain (CHD), a conserved catalytic MYST domain 
which was composed of a zinc finger and histone acetyltransferase domain (HAT), and a C-
terminus nuclear receptor-interacting (NR) box.  Figure adapted from Sapountzi et al., 2006. 
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proliferation, and senescence (Sapountzi et al., 2006).  One study found that the NuA4 complexes 
of Tip60α and Tip60β were identical (Doyon et al., 2004) 
Table 2.4 Subunits of the NuA4 complex in H. sapiens and their homologs from D. melanogaster 
and S. cerevisiae 
H. sapiens D. melanogaster S. cerevisiae Function 
Tip60 dTip60 Esa1 Acetyltransferase 
TRRAP dTra1 Tra1 PIKK domain 
p400/Domino Domino Eaf1/Swr1a SWI1/SWI2-like ATPase 
RuvBL1 dPontin Rvb1a Helicaseb 
RuvBL2 dReptin Rvb2a Helicaseb 
Actin Act87E Act1 ATPase, cytoskeleton 
BAF53 BAP55 Arp4 Actin-related domain, DNA repair 
Mrg15 dMrg15 Eaf3 Chromodomain, senescence 
MrgBP dMrgBP Eaf7 Scaffold Protein 
ING3 dIng3 Yng2 
PHD finger domain, growth inhibitor, 
apoptosis 
Epc1 E(Pc) Epl1 Transcription control, silencing 
Epc-like protein   Transcription regulation 
Brd8/TRCp120 dBrd8 Bdf1a 
Bromodomain, thyroid receptor 
coactivator 
YL-1 dYL-1 Vps72a Chromatin remodelling 
DMAP dDMAP1 Eaf2 SANT domain, DNA replication 
Gas41 dGas41 Yaf9 YEATS domain, cell viability 
FLJ11730 dEaf6 Eaf6  
(H2A.X/H2A.Z)c H2Av H2A/H2A.Za Histones 
(H2B)c H2B H2Ba Histones 
a – Subunits belong to a distinct SWR1 complex in yeast.  b – RuvBL1/2 do not appear to 
contribute to helicase activity in H. sapiens NuA4 complex.  c – Histones H2A.X/H2A.Z and 
H2B have not yet been confirmed in the H. sapiens NuA4 complex (Sapountzi et al., 2006) 
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Initially, Tip60 was thought to be involved in the regulation of viral gene expression by 
acting as a cofactor to the HIV-1 Tat protein (Yang et al., 2012).  It was originally proposed that 
Tip60 interacted with the N-terminal of the Tat protein, subsequently leading to Tat activation 
and the promotion of RNA polymerase phosphorylation, which led to increased HIV gene 
expression (Kamine et al., 1996).  However, it was later found that Tip60 possessed HAT activity 
and that it was able to acetylate the ε-amino group of lysine residues located on both histone and 
non-histone proteins (Sun et al., 2010).  This wide range of acetylation targets included core 
histone proteins H2A and H4, several transcription factors including Myc (Sapountzi et al., 2006) 
and p53 (Tang et al., 2006), the androgen receptor (Jeong et al., 2011), and ATM kinase 
(Squatrito et al., 2006).  The involvement of Tip60 with a wide range of proteins indicates that it 
plays a vital role in numerous cellular processes, including transcriptional regulation, DNA 
damage repair (Sapountzi et al., 2006), chromatin remodeling (Kusch et al., 2004), histone 
acetylation (Jeong et al., 2011), and apoptosis (Ikura et al., 2000).  Due to Tip60’s involvement 
in a diverse amount of cellular processes, the deregulation of Tip60 has been implicated in several 
human diseases, including Alzheimer’s disease (Pirooznia et al., 2012) and some cancers 
(Avvakumov and Cote, 2007; Sun et al., 2010). 
2.4.2 Tip60 and Transcriptional Regulation 
Through the regulation of a variety of transcription factors, Tip60 and the NuA4 complex 
were able to influence gene expression.  Tip60’s ability to function as a transcriptional regulator 
was dependent upon the specific promoter sites or the cellular context (Kim et al., 2012).  In 
some cases, Tip60 has been found to function as a coactivator of gene expression, whereas in 
other cases it serves to repress gene expression (Sapountzi et al., 2006).  Tip60’s ability to act as 
a coactivator of gene expression typically involves the acetylation of core histones located at the 
target promoter (Kim et al., 2012).  Additionally, Tip60 was found to associate with other 
transcription factors, such as HIV-1 Tat, Type I nuclear hormone receptor, and the amyloid-β 
precursor protein (Kim et al., 2012).  In the case of p53, it was found that Tip60 directly acetylates 
the transcription factor itself and controls its transcriptional activity (Tang et al., 2006). 
One study found that Tip60 served to enhance the transcription of estrogen receptor alpha 
(ERα) target genes through the direct interaction with ERα (Jeong et al., 2011).  The proposed 
model (Figure 2.15) for this interaction stated that Tip60’s LXXLL motif, found in its NR box, 
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first interacts directly with ERα.  The occupancy of Tip60 at the gene was then stabilized by the 
chromodomain binding to mono-methylated lysine four of histone H3 (H3K4Me1).  This binding 
of the chromodomain was then proposed to result in the activation of Tip60, which resulted in 
the acetylation of lysine five on histone H2A (H2AK5Ac) leading to chromatin remodeling and 
eventual transcription of the target genes (Jeong et al., 2011). 
The transcription of active genes requires RNA polymerase II to transcribe a DNA 
template into RNA (Veloso et al., 2014).  The control of the three stages of transcription, which 
include initiation, elongation, and termination, determines the level of gene expression (Veloso 
et al., 2014).  As previously described, nucleosomes pose a barrier to transcription and, therefore, 
the eviction of histones is critical to allow for transcriptional elongation to proceed (Ginsburg et 
al., 2009).  Studies on the Tip60 homolog Esa1 in S. cerevisiae revealed that Esa1 and the NuA4 
complex play a role in transcriptional elongation (Ginsburg et al., 2009).  It was proposed that 
NuA4 complex was recruited to promoters where it acetylates histone H4 in the promoter region, 
which results in the assembly of the preinitiation complex and, subsequently, a NuA4 complex 
was thought to associate with phosphorylated RNA polymerase II within the coding sequence 
(Ginsburg et al., 2009).  The NuA4 complex within the coding region was then proposed to 
interact with methylated lysine residues on histone H3, which mediates the acetylation of histone 
H4 (Ginsburg et al., 2014; Ginsburg et al., 2009).  The acetylation of histone H4 was found to 
result in the recruitment of chromatin remodeling complexes, which would result in the eviction 
of histones and subsequently increase the rate of transcriptional elongation (Ginsburg et al., 
2009).  Furthermore, a recent study found that the tri-methylation of lysine 4 on histone H3 
(H3K4Me3) and the hyper-acetylated H2A variant, H2A.Z, were found at the promotor region of 
highly expressed loci (Kusch et al., 2014).  The presence of H3K4Me3 resulted in the exchange 
of acetylated-H2A.Z by the Tip60 complex, which then stimulates the release of RNA 
polymerase II into elongation (Kusch et al., 2014). 
As previously stated, Tip60 also possesses the ability to function as a repressor of gene 
expression.  Typically, its repressor function manifest itself through the recruitment of other 
repressor complexes, such as the recruitment of deacetylases (Sapountzi et al., 2006).  An 
example of this is shown in the repression of the transcription factor signal transducer and 
activator of transcription 3 (STAT3), as it was found that Tip60 recruits the histone deacetylase 
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HDAC 7 to repress STAT3 activity (Xiao et al., 2003).  In the case of cAMP response element 
binding protein (CREB), it was found that Tip60 bound directly to the transcription factor to 
repress CREB function (Gavaravarapu and Kamine, 2000).  It was also found that Tip60 
associated with transcriptional repressors, such as the zinc finger E box (ZEB) binding protein to 
activate its repressor activity (Sapountzi et al., 2006). 
Due to the role Tip60 plays in transcriptional regulation, Tip60 itself must be tightly 
regulated.  One study found that the deacetylation of Tip60’s MYST domain by NAD+ - 
dependent histone deacetylase (HDAC) SIRT1 inhibits the acetyltransferase activity of Tip60 
and promotes its ubiquitin-dependent degradation (Peng et al., 2012).  Another method of 
regulation was to target Tip60 for proteosomal degradation, through the ubiquitination of the 
protein by mouse double minute 2 (Mdm2) protein when no stimuli were present (Sapountzi et 
al., 2006).  It was found that when a DNA double strand break is detected, the Mdm2 
ubiquitination of Tip60 is inhibited, which allows for an increase in Tip60 expression levels and 
its participation in the double-strand break repair pathway (Sapountzi et al., 2006). 
 
 
Figure 2.15 Proposed model for Tip60 regulated transcriptional activation of ERα target genes.  
A. Tip60 is initially targeted to ERα and interacts directly through its LXXLL motif found in 
Tip60’s NR box.  B. Tip60’s occupancy at the gene was stabilized through the binding of the 
Tip60 chromodomain to H3K4Me1.  C. The binding of the chromodomain to H3K4Me1 was 
proposed to activate Tip60’s acetyltransferase activity.  This resulted in the acetylation of 
H2AK5, which leads to chromatin remodeling and eventual transcription of target genes.  Figure 
adapted from Jeong et al., 2011. 
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2.4.3 Tip60 and Double-Strand Break Repair Pathway 
Cellular exposure to endogenous and exogenous agents, such as replication errors, 
oxidative free radicals, or ionizing radiation, could result in damage to DNA (Sun et al., 2010; 
van Attikum and Gasser, 2009).  These sources of DNA damage could potentially result in 
double-strand breaks (DSBs); the inability to repair damaged coding regions of DNA could cause 
some mutations, which lead to apoptosis, or the mutations to tumour suppressor genes could 
result in uncontrolled cellular proliferation, ultimately leading to cancer (Fischle, 2009).  To 
counter the damage caused by DNA double strand breaks cells utilize the DSB repair pathway.  
Tip60 and the NuA4 complex were found to play a vital role in the DSB repair pathway (Squatrito 
et al., 2006).  Upon the induction of a double strand break, the MRE11-RAD50-NBS1 (MRN) 
complex binds to the break site and recruits the ataxia-telangiectasia mutated (ATM) kinase 
(Squatrito et al., 2006).  One study found that ATM kinase and Tip60 exist as a complex in cells 
independent of DNA damage and that upon detection of a DSB event ATM was rapidly acetylated 
by Tip60 resulting in the activation of ATM kinase (Sun et al., 2005).  Another study found that 
the MRN complex was required to target the Tip60-ATM complex to the site of DSBs (Sun et 
al., 2009).  It was proposed that upon the detection of the of a DSB recruits MRN and CK2 to the 
break site.  The CK2 recruitment was found to be required for the phosphorylation of HP1β 
allowing for its release from chromatin.  Upon the release of HP1β, the Tip60-ATM complex 
was recruited to the break site.  Tip60 was thought to interact with tri-methylated lysine nine of 
histone H3 (H3K9Me3) through its chromodomain.  It was proposed that the binding of the Tip60 
chromodomain to H3K9Me3 was responsible for the activation of its acetyltransferase domain 
(Figure 2.16) (Sun et al., 2009) 
Once the acetyltransferase domain of Tip60 was activated, it was able to acetylate and 
activate ATM kinase (Sun et al., 2009).  The activation of ATM kinase resulted in the 
phosphorylation of the mammalian histone variant H2A.X (Kusch et al., 2004).  Through the use 
of the Drosophila melanogaster model, a study demonstrated that when H2Av (D. melanogaster 
homolog to H. sapiens H2A.X) became phosphorylated during a DSB event, its exchange for 
unmodified H2Av was catalyzed by the NuA4 complex (Kusch et al., 2004).  It was found that 
the Tip60 subunit would acetylate the phosphorylated-H2Av, which would allow the 
p400/Domino subunit of the NuA4 complex to exchange the phosphorylated-H2Av for 
unmodified H2Av (Kusch et al., 2004). 
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2.5 Summary of Previous Studies on Tip60 
Previous research on Tip60 has demonstrated its involvement in a variety of cellular 
processes, including transcriptional regulation, DNA damage repair, chromatin remodeling, and 
apoptosis.  As a histone acetyltransferase, Tip60’s role in the aforementioned cellular processes 
typically includes the acetylation of other proteins required in these processes.  The acetylation 
targets were found to include core histone proteins, transcription factors, the androgen receptor, 
and ATM kinase.  Due to Tip60’s diverse role, the deregulation of Tip60 has often been 
implicated in human disease. 
Several studies have been conducted to ascertain the mechanism by which Tip60’s 
acetyltransferase activity is regulated.  These studies suggested that the Tip60 chromodomain 
was responsible for targeting methylated lysine residues found on histone tails and allosterically 
regulating the HAT activity.  It was suggested that the Tip60 chromodomain was able to bind 
methyllysine through an aromatic cage.  However, studies conducted on the Tip60 homolog, Esa1 
and Tip60 paralog, MOF, revealed that the residues required to form an aromatic cage are not 
present.  Therefore, it is unlikely Tip60 is able to bind methyllysine through the proposed 
mechanism.  Currently, the binding partners of the Tip60 chromodomain have not been 
confirmed and the mechanism with which this binding is achieved is still unknown.  This research 
aims to determine the structure of the Tip60 chromodomain through X-ray crystallography and 
elucidate the binding partners of the chromodomain through in vitro binding studies. 
Figure 2.16 Proposed model for ATM activation. Detection of DSBs recruits MRN and CK2. 
Phosphorylation of HP1β by CK2 releases HP1β (green crescents) from chromatin. Tip60-ATM 
complex is recruited to the break site, where Tip60 chromodomain interacts with H3K9Me3 
(yellow spheres) stimulating HAT activity and subsequent acetylation and activation of ATM 
kinase. Figure adapted from Sun et al., 2009. 
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3 MATERIALS AND METHODS 
3.1 Reagents 
Table 3.1 List of reagents and suppliers 
Reagents Supplier 
1,4,7,10,13,16-hexaoxacyclooctadecane (18-crown-6) Sigma Aldrich 
Al’s Oil Hampton Research 
Ammonium Chloride (15N) Cambridge Isotope Laboratories 
Ampicillin Bioshop 
Centrifugal Filter Units Merck Millipore 
Chloramphenicol Sigma-Aldrich 
N-Cyclohexyl-2-aminoethanesulfonic acid (CHES) Bioshop 
Dialysis tubing BioDesign Dialysis Tubing 
Dithiothreitol (DTT) Bioshop 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
(EDC) 
BioRad 
Ethylenediamine Sigma-Aldrich 
Ethylenediaminetetraacetic acid (EDTA) Bioshop 
L-Glutathione reduced Sigma-Aldrich 
Glutathione Sepharose 4B GE Healthcare Life Sciences 
HydraGreen ACTGene 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) Fisher Scientific 
Hen Egg White Lysozyme Bioshop 
2-Methyl-2,4-pentandediol (MPD) Hampton Research 
N-hydroxysulfosuccinimide (sulfo-NHS) BioRad 
Polyethylene glycol (PEG) 3350-8000 Hampton Research 
PreScission Protease Amersham Biosciences 
Tris(2-carboxyethyl)phosphine (TCEP) Hampton Research 
Tween-20 Sigma-Aldrich 
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Table 3.2 List of kits and suppliers 
Kit Supplier 
Additive Screen (HR2-428) Hampton Research 
(NH4)2SO4 Suite Qiagen 
HR2-110 Crystal Screen Kit Hampton Research 
HR2-144 Crystal Screen Kit Hampton Research 
JCSG+ Suite Qiagen 
PACT Suite Qiagen 
QIAprep spin mini-prep columns Qiagen 
QIAquick gel extraction kit Qiagen 
QIAquick PCR purification kit Qiagen 
Plasmid Maxi kit Qiagen 
Wizard I Rigaku Reagents 
Wizard II Rigaku Reagents 
 
Table 3.3 Name and addresses of suppliers 
Supplier Address 
ACTGene Piscataway, New Jersey, USA 
Amersham Biosciences Piscataway, New Jersey, USA 
Amersham PharmaciaBiotech Uppsala, Sweden 
BioDesign Dialysis Tubing New York, USA 
Bio-Rad Hercules, California, USA 
Bioshop Burlington, Ontario, Canada 
Cambridge Isotope Laboratories Andover, Massachusetts, USA 
Constant Systems Daventry, United Kingdom 
Fisher Scientific Fair Lawn, New Jersey, USA 
GE Healthcare Life Sciences Uppsala, Sweden 
Hampton Research Aliso Viejo, California, USA 
Merck Millipore Tullagreen Carrigtwohill, Ireland 
Qiagen Toronto, Ontario, Canada 
35 
 
Rigaku Reagents Bainbridge Island, Washington, USA 
Sigma-Aldrich St. Louis, Missouri, USA 
Syngene Frederick, Maryland, USA 
TA Instruments Toronto, Ontario, Canada 
Thermo Scientific Waltham, Massachusetts, USA 
 
3.2 DNA Methods 
3.2.1 Cloning 
Initially four constructs were designed and cloned from an E. coli codon optimized 
synthetic DNA sequence of Homo sapiens Tip60 splice variant β and full length cDNA of 
Drosophila melanogaster Tip60 (provided by Drosophila Genetic Resource Centre).  The 
constructs were designed to separately clone the H. sapiens Tip60 chromodomain (residues 3 – 
72) and HAT domain (residues 68 – 459) and the D. melanogaster Tip60 chromodomain 
(residues 19 – 88) and HAT domain (residues 246 – 541).   The separate cloning of each domain 
allowed for the separate insertion of each domain into the multiple cloning sites (MCS) of the 
pGEX-6P-3 expression vector (GE Healthcare Life Sciences) between the EcoRI and BamHI 
restriction sites.  The major features of the pGEX-6P-3 expression vector (Figure 3.1A) are the 
glutathione S-transferase (GST) gene upstream of the MCS, where the gene of interest would be 
inserted, and the antibiotic resistance gene that allowed for the selection of successful 
transformants.  The GST gene’s position upstream of the MCS allowed for the gene of interest 
to be expressed as a GST-fusion protein, which in turn allowed for the recombinant protein to be 
purified through glutathione sepharose affinity purification.  Additionally, a PreScission protease 
recognition site is located within the linker region between the GST tag and the protein of interest, 
which allowed for the cleavage of the GST tag from the protein of interest.  PreScission protease 
is a highly specific fusion protein composed of GST and human rhinovirus 3C protease (Walker 
et al., 1994) that cleaves between Gln and Gly residues found in the recognition sequence Leu-
Glu-Val-Leu-Phe-Gln/Gly-Pro (Figure 3.1B) (Cordingley et al., 1990). 
The targeted gene fragments were produced by the polymerase chain reaction (PCR).  The 
cloning and amplification of the D. melanogaster Tip60 chromodomain and HAT domain utilized 
1 ng of template cDNA in 100 µL of the PCR reaction mixture composed of 1X reaction buffer 
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(200 mM Tris-HCl pH 8.8, 100 mM (NH4)2SO4, 100 mM KCl, 1 mg/mL BSA, 1% (v/v) Triton 
X-100, 20 mM MgSO4), 200 µM dNTPs, 200 nM 5’ forward primer, 200 nM 3’ reverse primer, 
2.5 units/µL Pyrococcus furiosus (Pfu) DNA polymerase, and H2O.  Thirty cycles of PCR 
amplification were performed using the MyCycler Thermal Cycler (Bio-Rad).  The PCR 
amplification protocol used is shown in Figure 3.2. 
For the cloning and amplification of the H. sapiens Tip60 chromodomain 1 ng, 2 ng, and 
4 ng of template cDNA were used to identify which yielded the optimal level of amplification of 
the target gene.  The template cDNAs and 1 – 4 mM MgSO4 were added to 50 µL of the PCR 
reaction mixture previously described.  The additional Mg2+ ions aid in the stabilization of the 
PCR reaction, which allowed for a greater yield of target DNA.  The cloning and amplification 
of the H. sapiens Tip60 HAT domain utilized different template cDNA concentrations, which 
ranged from 1 – 4 ng.  The template cDNAs were added to 50 µL of the PCR reaction previously 
described.  All primers used are listed in Table 3.4. 
Following PCR amplification, the PCR products were purified by ethanol precipitation.  
The purification was performed by adding 10% v/v of 3 M sodium acetate to the PCR products 
followed with a wash of 3X v/v of the PCR reaction mixture with 95% ethanol.  The solution was 
then incubated at -20° C for 10 minutes and then the sample was pelleted by centrifugation at 16, 
438 x g at 4° C for five minutes.  The supernatant was removed and 2X of 70% ethanol was added 
to the mixture.  The sample was then pelleted once more at 16, 438 x g at 4° C for five minutes.  
The supernatant was removed and the pellet dried by centrifugal evaporation.  Once the pellet 
was dry, it was re-dissolved in 20 µL TE (10 mM Tris-HCl pH 7.5 and 1 mM EDTA). 
 
37 
 
 
Figure 3.1 Map of the pGEX-6P-3 expression vector.  A. Features of the pGEX-6P-3 expression 
vector shown include the lacI gene, the GST gene, the PreScission protease cut site, the MCS, 
the endonuclease cut sites for EcoRI and BamHI, and the ampicillin resistance gene.  B. Gene 
sequence and amino acid sequence of the PreScission protease cut site and MCS.  The PreScission 
protease cut site is located between Gln and Gly as indicated by the arrow.  The endonuclease cut 
sites for BamHI and EcoRI are also indicated.  Figure generated using SnapGene software (GSL 
Biotech). 
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Table 3.4 List of primers 
Protein Primer Sequence Restriction 
Endonuclease 
D. melanogaster 
Tip60 
chromodomain 
5’-GACCTGGGATCCTAACGGCCGCCCTAACC-3’ 
5’-GACGAGGAATTCCTAGCCGTCTCTCCGCGGAAA-3’ 
BamHI 
EcoRI 
D. melanogaster 
Tip60 HAT 
domain 
5’-GACCTGGGATCCATGGTTACGCACCAGGACGAC-3’ 
5’-GACGAGGAATTCTCATTTGGAGCGCTTGGACCA-3’ 
BamHI 
EcoRI 
H. sapiens Tip60 
chromodomain 
5’-GACCTGGGATCCGGTGAAATTATTGAAGGCTGCCGT-3’ 
5’-GCGCCGGAATTCTCACTCTTTCTTGGGGAACTGGATCTT-3’ 
BamHI 
EcoRI 
H. sapiens Tip60 
HAT domain 
5’-GACCTGGGATCCCACGACGACATCGTCACC-3’ 
5’-GACGAGGAATTCTCACCACTTCCCCCTCTTGCT-3’ 
BamHI 
EcoRI 
 
Once the PCR products were purified by ethanol precipitation, the gene of interest was 
subjected to restriction digestion with the EcoRI and BamHI restriction endonucleases.  For the 
restriction digest, a 50 µL mixture composed of 2 µL EcoRI, 2 µL BamHI, 20 µL of purified gene 
of interest, 2X Tango buffer (66 mM Tris-acetate (pH 7.9 at 37° C), 20 mM magnesium acetate, 
Figure 3.2 PCR amplification program. 
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132 mM potassium acetate, 0.2 mg/mL BSA), and H2O was prepared.  The restriction digestion 
reaction was performed at 37° C for 16 hours.  Afterwards, the restriction digest products were 
subjected to ethanol precipitation as previously described.  Following ethanol precipitation, the 
pellet was re-dissolved in 10 µL TE buffer.  The pGEX-6P-3 plasmid was also digested using 
this protocol however only 10 µL of plasmid DNA was required for the restriction digestion 
reaction. 
The gene of interest and plasmid DNA from the restriction digest were then run on a 1 % 
agarose gel (agarose gel electrophoresis protocol described in section 3.2.5).  The gel was then 
viewed on a UV transilluminator to locate the DNA bands of interest.  The portion of the gel 
containing the DNA bands were then cut out and placed into separate Eppendorf tubes.  The mass 
of the excised fragment was determined by recording the mass of the Eppendorf tube before and 
after the gel fragment was added.  The DNA was then purified using the Gel Extraction kit from 
Qiagen and followed the protocol enclosed.  The concentration and purity of the DNA insert was 
checked by using a NanoDrop 2000 spectrophotometer (Thermo Scientific) measuring 
absorbance at 260 nm and then by agarose gel electrophoresis. 
Once the insert and plasmid had been subject to a restriction digestion and purified, a 
ligation reaction was performed.  The ligation reaction required that the molar ratio of the insert 
DNA to plasmid DNA be 5 to 1.  Additionally, 1 µL T4 DNA ligase, 1X (50 mM Tris-HCl (pH 
7.5 at 25° C), 10 mM MgCl2, 1 mM ATP, 10 mM DTT), H2O were also added to the ligation 
reaction mixture.  The ligation mixture was then incubated for 16 hours at 16° C or 4 hours at 
22° C. 
3.2.2 Preparation of Competent Cells 
Three different strains of E. coli competent cells were used during this project, XL-1, 
BL21(DE3), and Rosetta 2.  The XL-1 competent cells were used for cloning the gene of interest 
as these cells were designed for routine cloning applications and have a high transformation 
efficiency.  By design XL-1 competent cells are deficient of endonuclease (endA) and 
recombination (recA), which results in the improved quality of plasmid preparation DNA and 
insert stability respectively.  The BL21(DE3) and Rosetta 2 competent cells were used for protein 
expression.  BL21(DE3) competent cells feature an integrated copy of T7 RNA polymerase, 
which is induced by IPTG, and is deficient in lon and ompT proteases to facilitate the production 
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of the protein of interest. The Rosetta 2 strain is a BL21 derivative, which has been designed to 
improve the expression of eukaryotic proteins through the inclusion of a plasmid coding for seven 
tRNAs that match eukaryotic codons rarely used in E. coli.  The XL-1 and BL21(DE3) strains 
contain no antibiotic resistance, whereas the Rosetta 2 strain contains a chloramphenicol 
resistance gene located on the tRNA plasmid.  To prepare the competent cells the desired strain 
was plated onto Luria-Bertani (LB) medium agar plates which contained no antibiotics for XL-1 
and BL21(DE3) strains and 34 µg/mL chloramphenicol for the Rosetta 2 strain.  The plated cells 
were then incubated for 16 hours at 37° C.  Following incubation, a single colony was picked and 
used to inoculate 5 mL of LB broth media, which contained no antibiotics for XL-1 and 
BL21(DE3) strains and 34 µg/mL chloramphenicol for Rosetta 2 strain.  The inoculated LB broth 
media was then incubated in a shaking incubator at 37° C for 16 hours and shaking at 250 rpm.  
The seed culture was then diluted 1 in 100 times with fresh LB broth media, which contained the 
appropriate antibiotics.  The diluted culture was then incubated at 37° C in a shaking incubator 
shaking at 250 rpm until an optical density at 600 nm (OD600) of 0.4 to 0.6 was reached.  The 
OD600 was checked using a NanoDrop 2000 spectrophotometer (Thermo Scientific).  Upon 
achieving the desired OD600 the cells were chilled on ice and then harvested by centrifugation 
with a Beckman-Coulter centrifuge.  The cells were centrifuged for five minutes at 1,932 x g and 
4° C.  The cell pellet was then re-suspended in ice cold 0.1 M MgCl2 in a 1 to 5 v/v ratio of the 
original 100 mL cell volume.  The re-suspended cells were then incubated on ice for one hour.  
Following the incubation, the cells were then centrifuged for five minutes at 1,932 x g and 4° C.  
The cell pellet was then re-suspended in an ice cold solution composed of 0.1 M CaCl2 and 14% 
glycerol in a 1 to 50 v/v ratio of the original 100 mL cell volume.  The cells were then incubated 
on ice for one hour.  Aliquots of the cell solution were made and flash frozen with liquid N2 and 
stored at -80° C. 
3.2.3 Transformation of Bacterial Cells 
The transformation of XL-1 E. coli cells required that the entirety of the ligation mixture 
be added to 100 µL of cells.  The cells were then cold shocked by incubation at 4° C for 30 – 45 
minutes.  Following incubation, the cells were plated onto a pre-warmed LB agar plate which 
contained 100 µg/mL of ampicillin.  The plated cells were then incubated for 16 hours at 37° C.  
Afterwards the plates were stored at 4° C until needed.  The BL-21 and Rosetta 2 E. coli strains 
were used for protein expression and 40 – 80 ng of plasmid DNA was used to transform these 
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strains.  The transformation procedure used was the same as described previously.  For the 
transformation of the Rosetta 2 E. coli strain 34 µg/mL of chloramphenicol was also added to the 
LB agar plate. 
3.2.4 Plasmid Preparation 
Following the transformation of XL-1 E. coli cells the transformant colonies were 
screened by colony PCR.  The colony PCR was carried out to check for the presence of the gene 
of interest.  To perform the colony PCR, 250 µL reaction mixture was prepared to screen ten 
colonies.  The reaction mixture was composed of 1X reaction buffer (10 mM Tris-HCl pH 8.3, 
50 mM KCl, 1.5 mM MgCl2), 5 units/µL Thermus aquaticus (Taq) DNA polymerase, 200 µM 
dNTPs, 200 nM 5’ forward primer complementary to the 3’ end of the GST gene, 200 nM 3’ 
reverse primer complementary to the 3’ end of the insert gene, and H2O.  The reaction mixture 
was then split into ten 25 µL aliquots and each aliquot was inoculated with a different 
transformant colony.  The PCR procedure used was the same as described previously.  The PCR 
products were then run on a 1% agarose gel as described in section 3.2.5 to check for the presence 
of the insert. 
Positive colonies were selected to inoculate 5 mL of LB broth containing 100 µg/mL of 
ampicillin and grown for 16 hours at 37° C shaking at 250 rpm.  Following incubation, 2 mL of 
culture were harvested in an Eppendorf tube by centrifuging at 15,588 x g for one minute.  The 
supernatant was then discarded and the pellet was subjected to the plasmid preparation process.  
The plasmid preparation was done by using the QIAprep Spin Miniprep Kit (Qiagen) and 
following the instructions provided.  To confirm the presence of the gene of interest a restriction 
digestion, PCR purification, and DNA sequencing were performed.  The restriction digestion 
followed the protocol previously described.  Sanger DNA sequencing was performed at the Plant 
Biotechnology Institute (PBI) at the National Research Council (NRC) of Canada in Saskatoon, 
SK. 
3.2.5 Agarose Gel Electrophoresis 
For the quantification and purification of the gene of interest, agarose gel electrophoresis 
was performed.  The composition of the agarose gel included 1% (w/v) agarose and 1X TAE 
solution (40 mM Tris-acetate, pH 8.0 and 1 mM EDTA).  The agarose was dissolved in TAE 
buffer by heating in a microwave for 30 – 45 second intervals until the agarose was completely 
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dissolved.  Once the agarose mixture had cooled a 1X concentration of HydraGreen (ACTGene) 
was added to allow for visualization of the DNA.  The gel mixture was then poured into a gel 
casting tray containing a 10 well comb and allowed to set.  The gel was then immersed in 1X 
TAE buffer.  The DNA samples were mixed with DNA loading dye to allow for visualization 
during the resolving phase.  The DNA samples and a DNA ladder were loaded into the wells and 
the gel was resolved at a constant 100 V for 45 to 60 minutes.  The HdyraGreen added to the 
agarose gel has fluorescence excitation maxima between 295 nm and 490 nm.  To visualize the 
DNA bands on the gel a 365 nm wavelength was used.  The resolved agarose gel was then 
photographed by a G:Box Chemi XX9 Gel Doc Imaging System (Syngene). 
3.3 Protein Expression and Purification 
The purification of proteins in this project was accomplished through the use of fast 
protein liquid chromatography (FPLC), specifically using the ÄKTA FPLC system developed by 
Amersham Pharmacia Biotech (now GE Healthcare Life Sciences). 
3.3.1 Protein Expression Trials 
Protein expression trials were conducted to find the optimal conditions for the expression 
of the H. sapiens Tip60 chromodomain and D. melanogaster Tip60 chromodomain.  Initially 
BL21(DE3) competent E. coli cells were transformed with 40 ng of the pGEX-6P-3 plasmid 
carrying the chromodomain insert and plated onto LB agar plates containing 100 µg/mL of 
ampicillin.  The plates were left to incubate for 16-18 hours at 37° C.  A single colony was then 
used to inoculate 5 mL of LB broth media (for clarity this will be referred to as the overnight 
culture) containing 100 µg/mL of ampicillin and was left to incubate for 16-18 hours at 37° C 
and shaking at 220 rpm.  Fifty millilitres of LB broth media containing 100 µg/mL of ampicillin 
was inoculated with 1% v/v of the overnight culture and grown at 37° C and shaking at 220 rpm 
until a desired optical density at 600 nm (OD600) was reached.  During the expression trial three 
different OD600 were chosen for protein induction which were 0.4, 0.6, and 0.8.  Once the desired 
OD600 were reached, a 5 µL aliquot was taken for sodium dodecyl sulphate – polyacrylamide gel 
electrophoresis (SDS-PAGE) analysis and the expression was induced with 0.1 mM of isopropyl 
β-D-1-thiogalactopyronoside (IPTG) at 37° C and 25° C for at least 16 hours.  Following 
induction, 5 mL of cell culture were pelleted by centrifugation at 15,588 x g for two minutes.  
The cells were re-suspended in 500 µL of 1X phosphate buffered saline (PBS) and were lysed 
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through sonication.  Another 5 µL aliquot was taken of the cell lysate for SDS-PAGE analysis.  
The cell lysate was then centrifuged at 15, 588 x g for two minutes.  The resultant supernatant 
was then moved to a clean Eppendorf tube and the remaining pellet was re-dissolved in 500 µL 
of 1X PBS.  Five microliter aliquots of the supernatant and re-dissolved pellet were also taken 
for SDS-PAGE analysis.  Twenty microliters of a 70% glutathione sepharose slurry was then 
added to the supernatant solution and incubated at 4° C for 1 hour while gently mixing.  Following 
incubation, the glutathione sepharose beads were pelleted by centrifugation at 1,476 x g for 20 
seconds.  The beads were washed five times in 200 µL 1X PBS and then re-suspended in 20 µL 
of SDS-PAGE loading buffer.  The aliquots prepared during the expression trials were then 
analysed through SDS-PAGE analysis following the protocol detailed in section 3.4.1.  The 
optimal conditions for protein expression were selected and scaled up to allow for large scale 
production of the protein of interest. 
The expression of the D. melanogaster Tip60 chromodomain was achieved by following 
the protocol previously described for conducting protein expression trials with a few alterations.  
The transformation and plating of the transformants used the same parameters as previously 
described.  The overnight culture was prepared as previously described in the protein expression 
trials except that the volume was increased to 50 – 100 mL of LB broth media; the concentration 
of ampicillin, the incubation time and temperature were the same.  One litre of LB broth media 
containing 100 µg/mL of ampicillin was inoculated with 1% v/v of the overnight culture and was 
grown at 37° C and shaking at 210 rpm until an OD600 of 0.8 was reached.  The expression of 
protein was induced with 0.1 mM IPTG at 25° C and shaking at 210 rpm for at least 16 hours.  
The cells were harvested by centrifugation for 20 minutes at 5,393 x g.  The cell pellet was re-
suspended in 3X volume of lysis buffer (50 mM Tris-HCl (pH 7.0), 150 mM NaCl, and 1 mM 
EDTA) to mass of cell pellet (e.g. 3 mL lysis buffer for every gram of cell pellet) and stored at -
20° C. 
3.3.2 Glutathione Sepharose Affinity Purification 
The purification of the GST-tagged chromodomain began with glutathione sepharose 
affinity purification using an ÄKTA FPLC and a HR 16/10 column packed with 22 – 25 mL of 
glutathione sepharose 4B (GE Healthcare Life Sciences).  The column was initially equilibrated 
with two column volumes of 1X PBS buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
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and 1.8 mM KH2PO4 at pH 7.3) until conductivity was stable.  The E. coli cells were thawed and 
1 mg/mL of lysozyme was added to aid in the lysis of the cells.  The cells were then lysed using 
the TS Series Benchtop Cell Disruptor (Constant Systems).  The lysate was then centrifuged at 
20,406 x g for one hour at 4° C.  Following centrifugation, the supernatant was loaded into a 60 
mL super loop on the ÄKTA FPLC and then injected onto the glutathione sepharose affinity 
column.  The absorbance at 280 nm was monitored to detect the amount of protein passing 
through the column throughout the purification process.  The flow-through fractions were 
collected and two to five column volumes of 1X PBS were used to wash out unbound protein.  
The GST-fusion protein bound the column and was eluted with a glutathione elution buffer 
composed of 50 mM Tris, 150 mM NaCl, and 10 mM reduced L-glutathione at pH 8.0. 
Following the initial GST affinity purification, the eluted fractions which contained the 
GST-fusion protein were pooled together and dialyzed in 4 L of cleavage buffer composed of 50 
mM Tris, 150 mM NaCl, and 1 mM EDTA at pH 8.0 for 12 – 16 hours at 4° C.  Afterwards, the 
fusion protein was cleaved by incubating 30 µL of PreScission protease for 16 hours at 4° C.  
After cleavage of the fusion protein, GST affinity purification was repeated.  The protein of 
interest, which no longer possesses the GST tag, was eluted in the flow through whereas the GST 
tag and PreScission protease remained bound to the column.  Aliquots of the fractions were taken 
and resolved by SDS-PAGE analysis to determine the level of purity of each fraction sample. 
3.3.3 Anion-exchange Purification 
Following glutathione sepharose affinity purification, the fractions containing the 
chromodomain were pooled together and dialyzed in a low salt buffer (50 mM Tris (pH 8.5) and 
10 mM NaCl) for at least 16 hours to prepare the protein for anion-exchange purification.  The 
protein was purified using a HR 16/5 column packed with 15 – 20 mL of Source 15Q beads (GE 
Healthcare Life Sciences).  The Source Q column was equilibrated with three column volumes 
of low salt buffer (50 mM Tris (pH 8.5) and 10 mM NaCl) until conductivity was stable.  The 
protein was then injected onto the column using a super loop and five column volumes of low 
salt buffer was used to wash out unbound protein.  The elution of the protein was achieved by 
using a mixture of low salt buffer and high salt buffer (50 mM Tris (pH 8.5) and 2 M NaCl).  The 
high salt buffer was gradually increased over 5.5 column volumes until the solution mixture, 
which flowed through the column, contained 25% high salt buffer (500 mM NaCl).  Aliquots of 
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the fractions were taken and resolved by SDS-PAGE analysis to determine the purity of each 
fraction sample. 
3.3.4 Size-Exclusion Chromatography 
Size-exclusion chromatography was performed to predict the oligomerization state of the 
D. melanogaster Tip60 chromodomain.  Following expression of the chromodomain, the protein 
was purified by glutathione sepharose affinity and anion-exchange as previously outlined.  
Following anion-exchange the protein was concentrated to 2 mg/mL and 500 µL of this 
concentrated protein solution was used for size-exclusion chromatography.  The Superdex 75 
10/300 GL column (GE Healthcare Life Sciences), which has a 23 mL bed volume and a 
molecular weight separation range between 3,000 and 70,000 Da, was used.  The running buffer 
used was composed of 50 mM Tris, pH 8.5, and 150 mM NaCl.  Additionally, the same size-
exclusion chromatography procedure was performed using a running buffer composed of 30 mM 
CHES, pH 9.5, and 200 mM NaCl to determine if the storage buffer caused the oligomerization 
state of the chromodomain to change. 
Initially, the Superdex 75 10/300 GL column was equilibrated with three column volumes 
of running buffer.  Following equilibration, the protein was injected into the column and the 
fractions were collected.  The volume at which the protein was eluted was compared to a 
molecular weight standard which showed the eluted volume for proteins of various sizes. 
3.3.5 Buffer Exchange and Protein Concentration 
Following purification, the pure protein was first buffer exchanged into a storage buffer 
where the composition was dependent on what study the protein was to be used for.  The buffer 
exchange process was the same regardless of the storage buffer.  Initially, the purified protein 
solution volume was reduced to approximately 7 mL by centrifugation at 2,218 x g for 20 minutes 
at 4° C using a 15 mL Amicon Ultra Centrifugal filter (EMD Millipore) with a 3,000 Da 
molecular weight cut off.  Following this reduction in protein solution volume, an equal amount 
of storage buffer is added to the centrifugal filter device and centrifugation is repeated.  The 
process of volume reduction and storage buffer addition is repeated five times to complete buffer 
exchange into the storage buffer.  Once buffer exchange was completed, the protein solution was 
concentrated as desired through the use of the centrifugal filter and centrifugation, in a process 
similar to buffer exchange, except that no additional buffers were added as the volume was 
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reduced.  The concentration of the purified chromodomain was checked via a NanoDrop 2000 
spectrophotometer (Thermo Scientific) measuring the absorbance at 280 nm. 
For crystallization trials and ITC, the storage buffer was composed of 30 mM CHES pH 
9.5, 200 mM NaCl, 2 mM TCEP, and 10 % MPD.  The chromodomain was concentrated to 2.5 
mg/mL for use in crystallography trials.  For NMR studies the storage buffer was composed of 
40 mM phosphate buffer pH 7.5, 50 mM NaCl, and 5 % MPD.  The chromodomain was 
concentrated to 0.15 mM.  Initially, the SPR studies used a storage buffer composed of 30 mM 
phosphate buffer pH 7.4, 100 mM NaCl, 2 mM TCEP, and 10 % MPD.  The chromodomain was 
concentrated to 2.5 mg/mL for SPR studies. 
3.4 Protein Visualization Techniques 
3.4.1 Sodium Dodecyl Sulphate – Polyacrylamide Gel Electrophoresis 
Sodium dodecyl sulphate – polyacrylamide gel electrophoresis (SDS-PAGE) was utilized 
to visualize the protein following overexpression and purification.  All SDS-PAGE gels were cast 
with a 4% acrylamide stacking gel composed of 4% acrylamide, 124 mM Tris-HCl (pH 6.8), 
0.1% SDS, 0.1% ammonium persulfate (APS), 0.1 % N,N,N’,N’ – tetramethylethylenediamine 
(TEMED), and H2O.  The resolving gel was composed of 15% acrylamide, 373 mM Tris-HCl 
[pH 8.8], 0.1% SDS, 0.05% APS, 0.5% TEMED, and H2O.  The protein samples were prepared 
by mixing with 2X SDS gel loading buffer (100 mM Tris-HCl [pH 6.8], 4% w/v SDS, 0.2% w/v 
bromophenol blue, 20% v/v glycerol, and 200 mM β – mercaptoethanol) and boiled for 2 minutes.  
Ten microliters of sample was loaded into the wells of the stacking gel and the samples were 
resolved by applying a constant 120 V for approximately 2 hours or until the dye front reached 
the bottom of the resolving gel.  The running buffer used was composed of 24.8 mM Tris-HCl 
[pH8.2], 192 mM glycine, 0.1% w/v SDS, and H2O. 
The gel was then stained with coomassie blue stain (40% v/v ethanol, 10% v/v acetic acid, 
0.1% w/v Coomassie R250, and H2O) for 20 – 30 minutes and then destained with a destaining 
solution (40% v/v ethanol, 10% v/v acetic acid, and H2O) for 20 minutes and H2O for at least 4 
hours.  The gel images were captured using a G:Box Chemi XX9 Gel Doc Imaging System 
(Syngene). 
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3.5 Protein Crystallization 
3.5.1 Sparse Matrix Crystal Screening 
The commercially available sparse matrix crystal screen kit, Wizard Classic I (Emerald 
Biosciences now Rigaku Reagents) was initially used to identify potential crystallization 
conditions.  Crystal screens were setup by using the hanging drop vapour diffusion method, in 
which a droplet composed of 1 µL protein solution and 1 µL precipitant solution are suspended 
over a reservoir containing the same precipitant solution and allowed to equilibrate (Figure 3.3).  
The crystallization conditions were setup in 24 well plates and allowed to equilibrate at 20° C.  
Each condition was checked periodically for the presence of crystals.  The conditions which 
produced crystals were noted and selected for optimization.  Additionally, other sparse matrix 
screening kits such as the Wizard Classic II (Emerald Biosciences now Rigaku Reagents), JCSG+ 
Suite, PACT Suite, (NH4)2SO4 Suite (Qiagen), HR2-110 kit, and HR2-144 kit (Hampton 
Research) were used as well. 
 
Figure 3.3 Hanging drop vapour diffusion.  Droplet composed of a protein, buffer, and precipitant 
mixture was suspended above a reservoir containing the same buffer and precipitant.  The 
precipitant and protein concentration gradually increase in the drop as the system equilibrates 
and the water evaporates from the droplet. 
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3.5.2 Optimization of Crystal Screens 
Promising crystallization conditions from the initial sparse matrix screens were selected 
for optimization.  The optimization process was carried out in iterative steps in an attempt to 
identify the best condition for crystallization of the D. melanogaster Tip60 chromodomain.  
Typically, the precipitant concentration and pH of the buffer were varied first to probe around 
the initial condition identified by the sparse matrix screen.  An illustration of how the 
optimization procedure was performed is shown in Figure 3.4.  As the crystals improved in size 
and appearance, the concentration and buffer range of the solution was narrowed.  Conditions 
which yielded large single crystals were harvested for x-ray diffraction and data collection. 
 
Figure 3.4 Optimization of crystal screens.  Illustrated is a 24 well plate where one variable is 
increased moving from left to right and the other variable is decreased moving from top to bottom.  
The variables that could be changed include the pH, precipitant concentration, additive 
concentrations, salt concentrations, or buffer types at a constant pH. 
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3.6 Structure Determination and Refinement 
3.6.1 Collecting Diffraction Data 
The protein crystals were taken to the Canadian Light Source for x-ray diffraction and 
data collection.  To prepare the crystals for diffraction, cryo-protectants were prepared for each 
condition that generated crystals suitable for diffraction.  The cryo-protectants were composed of 
the same conditions which the crystals were grown in with glycerol and/or MPD added.  The 
cryo-protectant was added to the drop, which contained the crystals that were selected for 
diffraction.  The crystals were mounted using nylon loops (Hampton Research) and flash frozen 
with liquid nitrogen.  The data was collected at either the CMCF 08B1-1 Bending Magnet 
beamline or the CMCF 08ID-1 20 mm hybrid small gap in-vacuum undulator beamline. 
3.6.2 Molecular Replacement 
The diffraction data was processed with HKL2000 (Otwinowski and Minor, 1997).  The 
structure was solved using the PHASER molecular replacement program (McCoy et al., 2007) 
from the PHENIX software suite (Adams et al., 2010).  The search model used for molecular 
replacement was a poly-alanine model generated from the unpublished NMR structure of the H. 
sapiens Tip60 chromodomain (PDB ID: 2EKO) deposited in the Protein Data Bank (PDB).  The 
H. sapiens Tip60 chromodomain and the D. melanogaster Tip60 chromodomain share 70% 
sequence identity; therefore, it was expected the two proteins adopted similar structures. 
3.6.3 Model Building and Refinement 
The model building was achieved by using the molecular modeling software COOT 
(Emsley et al., 2010).  The first step of building the D. melanogaster Tip60 chromodomain model 
was to add side chain and backbone residues into the unoccupied areas of the electron density 
map.  Once the first series of changes were completed the updated model was run through the 
PHENIX refinement program.  The process of updating the model to fit side chain residues and 
backbone residues into the improved electron density map was repeated several times until the 
Rfree and Rwork no longer decreased in value. 
The R values were used to monitor the progress of the model building and refinement of 
the D. melanogaster Tip60 chromodomain was.  The R values were calculated using Equation 
3.1.  The Rwork value measured the agreement between the model and the experimental data, the 
lower the number the higher the degree of agreement between the model and experimental data.  
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The Rfree value randomly selected 5% of the experimental data to not be used during the model 
building or refinement process.  This ensured that no biases were introduced when model 
building.  The lower the Rfree, the better the model predicts the unused data. 
𝑅 =  
∑ hkl ||𝐹obs| − |𝐹calc||
∑ hkl |𝐹obs|
 
Equation 3.1 Calculation for the R factor values.  Where F is the structure factor amplitudes 
observed (Fobs) or calculated (Fcalc) for each reflection. 
3.7 Peptide Binding Experiments 
3.7.1 Preparation of Protein for Recording of 1H–15N HSQC Spectra 
The D. melanogaster Tip60 chromodomain was isotopically labelled with 15N for the 
NMR study.  To isotopically label the D. melanogaster Tip60 chromodomain, the initial protein 
expression conditions are altered to allow for the protein to be expressed as an isotopically 
labelled protein.  This was done by following the methods outlined in section 3.3.1 with the 
following changes; once an OD600 of 0.8 is obtained the E. coli cells are pelleted by centrifugation 
at 5,393 x g for 20 minutes and washed in M9 minimal media (22 mM KH2PO4, 90 mM Na2HPO4, 
8 mM NaCl, 22 mM D-glucose, 2 mM MgSO4, 0.1 mM CaCl2).  The pelleting and washing of 
the E. coli cells was repeated three times.  After the final wash step the cells were pelleted once 
more by centrifugation at 5,393 x g for 20 minutes and then re-suspended in 1 L of M9 minimal 
media (22 mM KH2PO4, 90 mM Na2HPO4, 8 mM NaCl, 22 mM D-glucose, 2 mM MgSO4, 0.1 
mM CaCl2) containing 1 g of 
15NH4Cl.  The cells were allowed a 20–30 minute recovery period 
at 37° C before induction.  The protein expression was induced with 0.1 mM IPTG for 12 – 16 
hours at 25° C and shaking at 210 rpm.  The cells were then harvested and the protein purified as 
outlined in section 3.3.  The protein was concentrated and stored as outlined in section 3.3.5. 
3.7.2 Surface Plasmon Resonance to Identify Potential Binding Partners of Tip60 
Chromodomain 
The surface plasmon resonance study was conducted at the Saskatchewan Structural 
Sciences Centre (University of Saskatchewan) and used the ProteOn XPR36 protein interaction 
array system from Bio-Rad.  This system provided a 6 x 6 interaction array, which allowed for 
up to six separate ligands to be immobilized onto the sensor chip surface and six separate analytes 
to be flowed over the sensor chip at once, which then allowed for the detection of 36 separate 
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interactions (Figure 3.5).  The D. melanogaster Tip60 chromodomain was covalently linked to 
the carboxylated alginate polymer surface of the sensor chip (GLM, Bio-Rad) through amine 
coupling.  The carboxyl groups were activated for ligand immobilization by injecting an 
activation solution containing a 1:1 mixture of 20 mM 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC) and 5 mM N-hydroxysulfosuccinimide (sulfo-NHS) in the vertical direction 
for 60 seconds.  This resulted in the formation of highly reactive sulfo-NHS esters that reacted 
with free amines exposed on the ligand surface, which in turn caused the ligand to immobilize 
onto the sensor chip surface.  Due to the overall negative charge of the sensor chip surface 
following activation, the ligand must have an overall positive charge which was achieved using 
immobilization buffers with a pH lower than the pI of the protein of interest.  For the D. 
melanogaster Tip60 chromodomain, 25 µg/mL was incubated with an immobilization buffer 
composed of 10 mM sodium malonate at pH 4.5.  Immobilization was accomplished by injecting 
the chromodomain in the vertical direction at a flow rate of 30 µL/min for five minutes.  It should 
be noted that, with SPR, it is assumed that the protein of interest will be immobilized in the same 
orientation and with all binding sites available. 
 
Figure 3.5 Schematic of the ProteOn XPR36 protein interaction array from Bio-Rad.  A. Initially 
the protein is immobilized to the sensor chip in the vertical direction (blue rectangles).  B. The 
sensor chip is then rotated to allow for analytes to be flowed in the horizontal direction.  The six 
horizontal channels (green rectangles) overlap the vertical channels (blue rectangles) at 36 unique 
locations (yellow).  This allows for 36 separate interactions to be measured at once. 
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To prevent the interaction between the sensor chip surface and the analytes, the activated 
and unreacted carboxyl groups were deactivated by injecting 130 mM ethylenediamine at a flow 
rate of 30 µL/min for five minutes in the vertical direction.  Upon the completion of the 
deactivation step, the response units (RU) were recorded to give an approximate value of the 
amount of protein immobilized.  Following the deactivation of unreacted carboxyl groups, a 
stable baseline was established through several washes of the sensor chip surface with running 
buffer composed of 50 mM HEPES (pH 7.4), 150 mM NaCl, 3 mM EDTA, 0.005% Tween20 
and a regeneration buffer composed of 10 mM glycine (pH 9.0), 0.5 M NaCl, 0.1% Tween20. 
Once the washing of the sensor chip was complete the system was ready for analytes to 
be injected.  The analytes used in this experiment were peptides, which correspond to sections of 
the H3 or H4 histone N-terminal tail sequences.  Additionally, some peptide sequences contained 
additional modifications to a lysine residue such as acetylation or methylation, which 
corresponded to post-translational modifications found on the N-terminal histone tails.  The 
peptides used are listed in Table 3.5.  These peptides were dissolved in the running buffer to 
minimize any refractive index changes between different buffers. 
To rapidly screen the peptide library for potential binding partners each peptide was 
injected at a concentration of 100 µM at a flow rate of 30 µL/min and the response monitored.  
Following each peptide injection, the sensor chip was washed with regeneration buffer to remove 
any bound peptides.  Every injection was double referenced; the first reference required that one 
ligand channel was activated/deactivated but no protein was immobilized; the second reference 
was to inject buffer over the immobilized protein.  The responses to both references were 
monitored and subtracted from the signal generated by the protein-peptide interaction. 
There are two common methods utilized for collecting kinetic data: pre-steady state and 
steady state experiments.  The steady state experiment allows for the dissociation constant (KD) 
of a binding interaction to be approximated.  The KD values for the histone tail peptides were 
measured by a steady state affinity experiment, which required ten different concentrations for 
each peptide.  The concentration ranges for the titrated peptides varied depending on the expected 
KD.  One group of peptides had concentrations which ranged from 1.85 µM to 300 µM; another 
group of peptides had concentrations which ranged from 6.17 µM to 1 mM.  The RUs from each 
interaction were then normalized using Equation 3.2 and the normalized responses were plotted 
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against the concentrations.  The normalization of the RUs allowed for the data obtained from 
each peptide to be compared.  The KD was then calculated using Equation 3.3.  The Rmax, which 
is the maximum theoretical response of a particular peptide interacting with the ligand, was 
calculated using Equation 3.4.  The Rmax value was used in the calculation of the KD. 
Table 3.5 Histone tail peptides for binding experiments 
Histone tail peptide N/C 
Terminus 
Sequence Molecular 
Weight (Da) 
H3K4Me1 Ac/Amide ART(KMe)QTARKSTGGY 1579 
H3K9Me3 Ac/Amide KQTAR(KMe3)STGGY 1281 
H3K27Me3 Ac/Amide SKAAR(KMe3)SAPAY 1234 
H3K36Me1 Ac/Amide STGGV(KMe)KPHRY 1284 
H3K36Me3 Ac/Amide STGGV(KMe3)KPHRY 1314 
H46-24 Unmodified H/NH2 GGKGLGKGGAKRHRKVLRDY 2153 
H4K12Ac NH2/Amide GGKGLG(KAc)GGAKRHRKVLRDY 2195 
H4K16Ac NH2/OH GGKGLGKGGA(KAc)RHRKVLRDY 2194 
H4K20Me1 NH2/Amide GGKGLGKGGAKRHR(KMe)VLRDY 2166 
H4K20Me1 short Ac/Amide YGAKRHR(KMe)V 1169 
H4K20Me3 Ac/Amide GAKRHR(KMe3)VLRDNY 1698 
H49-15  NH2/Amide GLGKGGAY 721 
H416-20  NH2/Amide KRHRKY 886 
H420-24 NH2/Amide KVLRDNY 793 
H4D24K NH2/Amide HRKVLRKNY 1212 
H4K20 short Ac/Amide YGAKRHRKV 1155 
H4R17A Ac/Amide YGAKAHRKV 1070 
H4R17E Ac/Amide YGAKEHRKV 1128 
H4H18A Ac/Amide YGAKRARKV 1089 
H4H18E Ac/Amide YGAKRERKV 1147 
H4R19A Ac/Amide YGAKRHAKV 1070 
H4R19E Ac/Amide YGAKRHEKV 1128 
*H413-20 Unmodified Ac/Amide YGGAKRHRKV 1212 
* – used only in ITC experiments 
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RU Normalized =  (
RU Observed
RU Ligand Immobilized
 ×  
Molecular Weight Ligand
Molecular Weight Analyte
) 
×  
Molecular Weight Heaviest Analyte
Molecular Weight Analyte of interest
 
Equation 3.2 The normalization equation for SPR.  The ratio of the response units observed for a 
particular peptide to the response units of the immobilized ligand was multiplied by the ratio of 
the molecular weight of the ligand to the peptide (analyte) of interest.  This value was then 
multiplied by the ratio of the molecular weight of the heaviest peptide used in the series to the 
peptide of interest. 
Req =
Rmax[A]
KD + [A]
 
Equation 3.3 Calculating KD at equilibrium.  Req is the response at equilibrium, Rmax is the 
maximum theoretical response of particular peptide interacting with the ligand, [A] is the 
concentration of peptide. 
Rmax=n
MA
ML
RL 
Equation 3.4 The Rmax equation calculates the maximum theoretical response of a particular 
peptide interacting with the ligand.  n is the stoichiometric value of the interaction, MA is the 
mass of the analyte (peptide), ML is the mass of the immobilized ligand, and RL is the amount of 
the ligand immobilized in response units (RUs). 
3.7.3 Isothermal Titration Calorimetry to Confirm and Characterize Interaction between Tip60 
Chromodomain and Peptides 
Isothermal titration calorimetry (ITC) was performed at the Protein Characterization and 
Crystallization Facility (University of Saskatchewan) and used the Nano-ITC from TA 
Instruments.  The protein and the peptides were prepared in a buffer composed of 30 mM CHES 
pH 9.5, 200 mM NaCl, 2 mM TCEP, and 10% MPD.  The H413-20 unmodified peptide was used 
in the ITC study and the sequence is listed in Table 3.5.  This peptide was selected based on the 
results from SPR. 
The D. melanogaster Tip60 chromodomain was concentrated to 0.34 mM (3.0 mg/mL) 
and 170 µL was placed into the reaction cell.  Two hundred microliters of buffer were placed into 
the reference cell and the 50 µL syringe was filled with 6 mM – 8.5 mM of the H413-20 unmodified 
peptide.  The syringe was placed into the sample cell, the temperature was set to 25° C, and the 
stir rate set to 200 rpm.  Once the stirring began, the system was allowed to equilibrate for 30 – 
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45 minutes until a stable baseline was achieved.  Once the baseline was stabilized the experiment 
was started.  The experiments were performed with either 21 or 26 total injections, using an 
injection volume of 2.5 µL or 2.02 µL respectively.  Two small volume injections were performed 
at the beginning of every injection series to minimize the equilibration artifacts typically seen 
with the first two injections of every series; these injections were not included in the data analysis. 
Once the initial peptide titration was completed, two series of reference titrations were 
also completed.  The first series of reference titrations used 50 µL of peptide loaded into the 
syringe and injected into the reaction cell containing 170 µL of buffer.  The second series of 
reference titrations used 50 µL of buffer loaded into the syringe and injected into the reaction cell 
containing 170 µL of protein.  Both series of reference titrations followed the same parameters 
used in the peptide into protein titrations.  Once all titrations were completed, the data could be 
analysed using the NanoAnalyze software from TA Instruments. 
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4 RESULTS 
4.1 Sequence alignment of the Tip60 chromodomain to other related chromodomains 
Previous studies conducted by two different research groups suggested that the Tip60 
chromodomain preferentially bound to either H3K9Me3 (Sun et al., 2009) or H3K4Me1 (Jeong 
et al., 2011) through the use of an aromatic cage.  The canonical chromodomain, HP1α was 
known to interact with H3K9Me3 through a hydrophobic cage composed of three aromatic amino 
acids (Nielsen et al., 2002).  The aforementioned research groups performed a sequence 
alignment between the Tip60 and HP1α chromodomains and found that Tip60 possessed a similar 
arrangement of conserved aromatic residues in its primary sequence (Trp26, Phe43, and Tyr47), 
presuming it to be required for H3K9Me3 binding (Jeong et al., 2011; Sun et al., 2009).  As 
previously discussed, Tip60 belongs to the MYST family of HATs and it was found that another 
member of this family, the males-absent-on-the-first (MOF) chromodomain, did not possess an 
aromatic cage (Conrad et al., 2012).  This was significant, as it was found that Homo sapiens 
MOF and H. sapiens Tip60 share approximately 45% sequence identity over the course of the 
entire protein (Peng et al., 2012). 
The high level of sequence identity between Tip60 and MOF over the entire protein 
indicated that the two proteins likely adopt similar structures.  To further examine this, a sequence 
alignment of the chromodomains belonging to Tip60, MOF, and Esa1 was performed (Figure 
4.1A).  The sequence alignment revealed a high level of sequence conservation between the 
MYST family members as expected.  However, a sequence alignment between the 
chromodomain containing MYST family members and the HP1α chromodomain showed poor 
sequence conservation.  Furthermore, it was found that the Tip60 chromodomain and HP1α 
chromodomain share only 17% sequence identity.  Due to the high level of sequence conservation 
between the Tip60 chromodomain and its related MYST family members, it was reasonable to 
speculate that the Tip60 chromodomain was likely to adopt a structure similar to the MOF or 
Esa1 chromodomain, as opposed to the HP1α chromodomain.  Furthermore, a previous study 
compared the chromodomains of MOF and HP1α and revealed that, not only does the MOF 
chromodomain lack an aromatic cage, but the residue Arg387 would actually interfere with 
methyllysine binding (Figure 4.1B) (Nielsen et al., 2005).  This information casts doubt onto the 
data published by Sun et al. (2009) and Jeong et al. (2011), attributing the methyllysine binding 
capabilities to the Tip60 chromodomain via an aromatic cage. 
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Figure 4.1 Comparison of different chromodomains.  A. Sequence alignment of the 
chromodomain containing MYST family members.  The residues highlighted in red show strict 
sequence identity whereas those residues highlighted in yellow and bolded show sequence 
similarity.  Sequence alignment was generated using clustal omega (Goujon et al., 2010; Sievers 
et al., 2011).  Secondary sequence features and conserved sequences identified using ESPript 
(http://espript.ibcp.fr) (Robert and Gouet, 2014).  B. Superimposed close-up view of the 
methyllysine binding pocket of MOF (magenta) and HP1α (cyan) chromodomains from D, 
melanogaster.  By superimposing the MOF chromodomain onto the HP1α chromodomain bound 
to H3K9Me2 (yellow) it was revealed that an arginine residue in the MOF chromodomain would 
interfere with methyllysine binding.  The key residues found in the HP1α binding pocket are 
coloured red and the equivalent residues in MOF are coloured green.  Figure 4.1B right panel 
adapted from Nielsen et al., 2005.  Overlay generated using CCP4 software suite (Sievers et al., 
2011; Winn et al., 2011) secondary structure matching program (Krissinel and Henrick, 2004). 
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4.2 Cloning of Homo sapiens and Drosophila melanogaster Tip60 domains 
The chromodomain and HAT domain of H. sapiens were cloned separately from E. coli 
codon optimized synthetic DNA and the D. melanogaster Tip60 chromodomain and HAT 
domain were cloned individually from full length cDNA sequences using PCR.  The domains 
were cloned separately to simplify the crystallization process.  The results from cloning the D. 
melanogaster Tip60 chromodomain and HAT domain are shown in Figure 4.2A.  The cloning of 
the H. sapiens Tip60 HAT domain are shown in Figure 4.2B.  The cloning of the H. sapiens 
Tip60 HAT domain yielded low concentrations of PCR products; therefore, different conditions 
were attempted to increase the yield of PCR products.  The template concentrations were varied 
from 1 ng/µL to 2 ng/µL in combination with using either Taq or Pfu DNA polymerases.  To 
further optimize the yield, the template concentration was increased to 4 ng/µL and 2 mM MgSO4 
was added, however, this proved to be unsuccessful (Figure 4.2C).  It was found that the use of 
Taq polymerase was unsuccessful for the production of any PCR products as seen in Figure 4.2B.  
Figure 4.2 Cloning of Drosophila melanogaster and Homo sapiens Tip60 chromodomains and 
HAT domains.  All DNA samples were run on 1 % agarose gel and HydraGreen was used to 
visualize the DNA.  A. Cloning of the D. melanogaster Tip60 chromodomain (CHD) and HAT 
domain. 1 ng/µL of template DNA was used.  B. Cloning of the H. sapiens Tip60 HAT domain 
used 1 – 2 ng/µL of template DNA and Taq or Pfu DNA polymerase.  Each lane contained 
different amount of template DNA as follows: Lane 1 - 1 ng/µL, Lane 2 - 2 ng/µL, Lane 3 – 1 
ng/µL, Lane 4 – 1.5 ng/µL, Lane 5 - ng/µL.  The reactions highlighted by the red box were 
combined together and used for transformation.  C. Cloning of the H. sapiens Tip60 
chromodomain with varying amounts of MgSO4.  Lanes 1 – 3 contained 2 ng/µL template DNA 
and varying amounts of MgSO4.  The amount of MgSO4 in lanes 1 – 3 is as follows: Lane 1 – 1 
mM, Lane 2 – 2 mM, Lane 3 – 4 mM.  Lane 4 contained 4 ng/µL of DNA template and 2 mM 
MgSO4.  The attempted optimization of the cloning of the HAT domain (lane 5) used 4 ng/µL of 
template DNA and an additional 2 mM MgSO4. 
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The inefficient cloning of the H. sapiens Tip60 domains could be attributed to the template DNA 
originating from an E. coli codon optimized synthetic DNA sequence. 
The cloned domains were subjected to a restriction digest using BamHI and EcoRI to cut 
the 5’ and 3’ ends of the insert respectively.  The inserts were then ligated into the pGEX-6P-3 
expression vector and used to transform XL-1 E. coli competent cells.  The cells were plated and 
the resultant colonies were screened by colony PCR (Figure 4.3).  Figure 4.3A shows the colony 
PCR results of the E. coli cells transformed with the pGEX-6P-3 expression vector carrying the 
D. melanogaster Tip60 chromodomain insert.  Of the eight colonies picked, only colonies 1 and 
8 do not appear to contain the chromodomain insert.  Colonies 2 – 7 clearly show the presence 
Figure 4.3 Colony PCR of Drosophila melanogaster and Homo sapiens Tip60 domains.  All 
DNA samples were run on 1 % agarose gel and HydraGreen was used to visualize the DNA.  A. 
Shows colony PCR of XL-1 E. coli cells transformed with the pGEX-6P-3 vector carrying the D. 
melanogaster Tip60 chromodomain insert.  The D. melanogaster Tip60 chromodomain insert 
was run alongside as a positive control.  B. Colony PCR of XL-1 E. coli cells transformed with 
pGEX-6P-3 vector carrying either the D. melanogaster Tip60 HAT domain or the H. sapiens 
Tip60 HAT domain.  The D. melanogaster Tip60 HAT domain insert was run alongside as a 
positive control.  C. Colony PCR of XL-1 E. coli cells transformed with the pGEX-6P-3 vector 
carrying the H. sapiens Tip60 chromodomain.  The H. sapiens Tip60 chromodomain insert was 
run alongside as a positive control. 
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of the D. melanogaster Tip60 chromodomain.  Colonies 6 and 7 were selected for sequencing as 
these were the most intense bands in the colony PCR gel which indicated that a higher 
concentration of the target DNA insert was present in the cells.  Figure 4.3B shows the results of 
colony PCR of the cells transformed with the pGEX-6P-3 vector carrying either the D. 
melanogaster Tip60 HAT domain or H. sapiens Tip60 HAT domain insert.  Of the colonies 
transformed with the D. melanogaster Tip60 HAT domain, only colony 1 did not have the insert 
present and colonies 2 and 4 were selected for sequencing as these appeared to have the most 
intense bands in the agarose gel.  The colonies transformed with the pGEX-6P-3 vector carrying 
the H. sapiens Tip60 HAT domain appeared to only have one positive result; colony 1.  Figure 
4.3C shows the result of colony PCR of the colonies transformed with the pGEX-6P-3 vector 
carrying the H. sapiens Tip60 chromodomain.  The screen revealed that colony 1 does not contain 
the insert, whereas colonies 2 and 3 show presence of the chromodomain insert.  Colonies 2 and 
3 were selected for DNA sequencing. 
To confirm the presence of the gene of interest in each of the positive colonies, a plasmid 
preparation, double restriction digest, and DNA sequencing were performed.  The sequencing 
data revealed that only two sequenced colonies did not contain the correct sequence for the gene 
of interest.  Two colonies, one of which contained the H. sapiens Tip60 chromodomain and one 
of which contained the H. sapiens Tip60 HAT domain, were unable to integrate the gene of 
interest into the expression vector successfully.  The results of the DNA sequencing are 
summarized in Table 4.1. 
Table 4.1 Colony PCR sequencing results 
Colony Number Gene of Interest Present Sequencing Result 
6 D. melanogaster Tip60 chromodomain Correct sequence 
7 D. melanogaster Tip60 chromodomain Correct sequence 
2 D. melanogaster Tip60 HAT domain Correct sequence 
4 D. melanogaster Tip60 HAT domain Correct sequence 
2 H. sapiens Tip60 chromodomain Incorrect sequence 
3 H. sapiens Tip60 chromodomain Correct sequence 
1 H. sapiens Tip60 HAT domain Incorrect sequence 
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4.3 Protein expression and purification 
Following the insertion of the chromodomains and the D. melanogaster HAT domain into 
the pGEX expression vectors, trials were conducted to determine the ideal growth and expression 
conditions of the constructs.  Initially, plasmids which contained the D. melanogaster Tip60 
chromodomain, HAT domain, and H. sapiens Tip60 chromodomain inserts were selected for the 
expression trials.  Due to the expression of the proteins of interest as GST fusion proteins, a GST 
pull down was utilized.  The expected size of the fusion proteins are as follows: H. sapiens Tip60 
chromodomain is 35.3 kDa, D. melanogaster Tip60 chromodomain is 35.2 kDa, and the D. 
melanogaster Tip60 HAT domain is 62 kDa. 
From the GST-pull downs it was found that the H. sapiens Tip60 chromodomain was 
optimally expressed in Rosetta 2 E. coli competent cells as opposed to BL21(DE3) E. coli 
competent cells (Figure 4.4).  When comparing the two bands in the GST-pull down lanes 
highlighted in Figure 4.4, it could be seen that the band corresponding to the fusion protein was 
much darker in the Rosetta 2 gel (Figure 4.4B), which indicated the presence of a higher 
concentration protein.  The most likely reason for this difference could be attributed to the Rosetta 
2 E. coli strain possessing the additional tRNAs for improved eukaryotic protein expression.  
Additionally, it should be noted that the presence of free GST in the GST-pull down lanes was 
likely due to incomplete protein synthesis by E. coli, resulting in the early termination of the 
recombinant protein’s synthesis or the presence of contaminants resulting in proteolytic cleavage 
(Figure 4.4). 
The expression trials for the D. melanogaster Tip60 chromodomain and HAT domain 
revealed the optimal conditions for the expression of both proteins.  For the HAT domain it was 
found that the protein was better expressed within the BL21(DE3) strain than the Rosetta 2 strain 
(Figure 4.5).  This could be seen when the bands (highlighted in red in Figure 4.5A and B) in the 
GST pull down columns were compared.  The band corresponding to the fusion protein in the 
BL21(DE3) gel appeared to be thicker than that in the Rosetta 2 gel, which indicated a higher 
concentration of protein. 
The D. melanogaster Tip60 chromodomain was found to be optimally expressed in the 
BL21(DE3) strain (Figure 4.6).  The amount of the GST-chromodomain fusion protein derived 
from D. melanogaster was significantly greater than the amount of GST-chromodomain fusion 
62 
 
protein derived from H. sapiens (Figure 4.6A and B).  For this reason, all subsequent experiments 
were carried out using the D. melanogaster Tip60 chromodomain. 
 
Figure 4.4 Results of protein expression trials for H. sapiens Tip60 chromodomain.  A. H. sapiens 
Tip60 chromodomain expressed in BL21(DE3) competent cells.  The chromodomain was 
expressed by induction with 0.1 mM IPTG at 25° C for 16 hours.  The GST-chromodomain fusion 
protein is highlighted in red.  B. H. sapiens Tip60 chromodomain expressed in Rosetta 2 
competent cells.  The chromodomain was expressed by induction with 0.1 mM IPTG at 25° C 
for 16 hours.  The GST-chromodomain fusion protein is highlighted in red. 
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Following the expression trials, large scale purification of the D. melanogaster Tip60 
chromodomain was carried out.  As described in section 3.3.2, the protein was initially purified 
with two rounds of glutathione sepharose affinity purification.  The first round of glutathione 
sepharose affinity purification was designed to separate the GST-tagged chromodomain from the 
cellular lysate (shown in the lane labeled “1st GST Eluate” in Figure 4.7A).  As outlined in section 
3.3.2, the GST-tagged chromodomain was subjected to cleavage by PreScission Protease (shown 
in the lane labeled “GST-DrosoCHD + PreScission Protease” in Figure 4.7A), followed by a 
second round of glutathione sepharose affinity purification.  This additional round of glutathione 
sepharose affinity purification resulted in the chromodomain being eluted free of the GST tag 
(highlighted in red in Figure 4.7A).  To further purify the protein, anion-exchange was performed 
using the method that was previously described in section 3.3.3.  The results of anion exchange 
Figure 4.5 Results of protein expression trials for D. melanogaster Tip60 HAT domain.  A. D. 
melanogaster Tip60 HAT domain expressed in BL21(DE3) competent cells.  Expression was 
induced with 0.1 mM IPTG at 25° C for 16 hours.  The GST-HAT fusion protein is highlighted 
in red.  B. D. melanogaster Tip60 HAT domain expressed in Rosetta 2 competent cells.  
Expression was induced with 0.1 mM IPTG at 25° C for 16 hours.  The GST-HAT fusion protein 
is highlighted in red. 
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showed that any impurities which had remained from the glutathione sepharose affinity 
purification had been removed; only the pure chromodomain remained (Figure 4.7B). 
Size-exclusion chromatography was also performed on the D. melanogaster Tip60 
chromodomain to determine its oligomerization state and follows the method outlined in section 
3.3.4.  It was important to elucidate the oligomerization state of the chromodomain, as it could 
have potential implications on how the protein packs in a crystal and what surfaces could be 
available for binding.  It was found that the chromodomain, which has a molecular weight of 
8.411 kDa, eluted at a volume of 14.97 mL (Figure 4.8).  A comparison of this volume to those 
of the proteins used in the molecular weight standard revealed that the chromodomain eluted 
between the volumes of the 6.5 kDa and 13.5 kDa standards.  This indicated that the 
chromodomain was a monomer in solution. 
 
Figure 4.6 Comparison between D. melanogaster Tip60 chromodomain and H. sapiens Tip60 
chromodomain.  A. D. melanogaster Tip60 chromodomain expressed in BL21(DE3) competent 
cells.  Expression was achieved through induction with 0.1 mM IPTG at 25° C for 16 hours.  The 
GST-chromodomain fusion protein is highlighted in red.  B. H. sapiens Tip60 chromodomain 
expressed in Rosetta 2 competent cells.  Expression conditions were identical to those listed in 
Figure 4.4B.  The GST-chromodomain fusion protein is highlighted in red. 
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Figure 4.7 Results of the protein purification of D. melanogaster Tip60 chromodomain.  A. The 
results of two rounds of glutathione sepharose affinity purification were shown.  The eluted GST-
chromodomain fusion protein could be seen in the lane labeled “1st GST Eluate”.  The cleaved 
products from the addition of PreScission Protease were shown in the lane labeled “GST-
DrosoCHD + PreScission Protease.”  The cleaved GST tag is seen between the 24 kDa and 29 
kDa markers and the chromodomain is seen close to the 6.5 kDa marker.  The results of second 
round of glutathione sepharose affinity purification was shown in the lanes labeled “2nd GST 
Flow through” and “2nd GST Eluate.”  During this round of purification, the chromodomain 
appeared in the flow through fractions (highlighted in red) and the GST tag remained bound to 
the column until eluted by the addition of excess glutathione.  The GST tag could be seen in the 
“2nd GST Eluate” lane.  B. The results of anion-exchange (SQ) purification of the chromodomain.  
The purified chromodomain is highlighted in red. 
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4.4 Crystal screening and optimization of crystallization conditions for Drosophila 
melanogaster Tip60 chromodomain 
Initial crystallization trials utilized the Wizard I sparse matrix screening kit from Emerald 
Biosciences (now Rigaku Reagents) to identify potential crystallization conditions for the 
chromodomain.  It was found from the sparse matrix screen that there were many conditions 
which produced crystals of the chromodomain.  The sparse matrix screen also revealed that many 
of these conditions were typically above or below the isoelectric point (pI) of the chromodomain 
(the pI was 6.06) by two pH units.  Additionally, many of the conditions used either a 
polyethylene glycol (PEG) of varying molecular weights (e.g. PEG3000 or PEG8000) or 
ammonium sulphate as the main precipitant reagent.  From the 48 different conditions screened 
in the kit, the most promising conditions were selected for further optimization (Figure 4.9).  
These conditions were selected on the basis that the crystals produced were fairly large and 
singular. 
Figure 4.8 Size-exclusion chromatography of the D. melanogaster Tip60 chromodomain.  
Chromatogram of the size-exclusion chromatography of the chromodomain.  Five hundred 
microliters of a 2 mg/mL protein solution was loaded onto a Superdex 70 10/300 column.  The 
absorbance at 280 nm was monitored during the elution of the protein.  The chromodomain eluted 
at 14.97 mL. 
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The crystallization conditions from the sparse matrix screen served as the basis for which 
to further investigate the crystallization space of the chromodomain.  From each condition 
selected there were two variables that were varied: the pH and the precipitant concentration.  By 
varying these conditions around the base condition found in the sparse matrix screen, it was 
possible to narrow down the optimal conditions for the production of large singular crystals.  The 
optimization process revealed that the conditions which produced the best crystals were 
composed of 0.1 M phosphate-citrate at a pH range of 4.6 – 5.4, 0.2 M NaCl, 10 % MPD, and 
Figure 4.9 Crystals of the D. melanogaster Tip60 chromodomain produced from the Wizard I 
Sparse Matrix screening kit.  All images shown were captured at 4X magnification.  The 
chromodomain was concentrated to 2.5 mg/mL and the hanging drop vapour diffusion method 
was used.  Each droplet was composed of 1 µL protein solution and 1 µL precipitant solution.  
A. The precipitant solution was composed of 0.1 M citrate (pH 5.5) and 20 % PEG3000.  B. The 
precipitant solution was composed of 0.1 M cacodylate (pH 6.5) and 1.26 M (NH4)2SO4.  C. The 
precipitant solution was composed of 0.1 M CAPS (pH 10.5), 0.2 M Li2SO4, and 1.2 M 
NaH2PO4/0.8 M K2HPO4.  D. The precipitant solution was composed of 0.1 M phosphate-citrate 
(pH 4.2), 0.2 M NaCl, and 20 % PEG8000. 
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PEG8000 at a concentration range of 18 – 24 % (Figure 4.10).  These crystals were found to be 
large and singular and suitable for x-ray diffraction and data collection.  The crystals were 
diffracted at the Canadian Light Source (CLS), where it was found that the condition composed 
of 0.1 M phosphate-citrate (pH 4.6), 0.2 M NaCl, 10 % MPD, and 22 % PEG8000 (Figure 4.10B) 
diffracted the best.  These results are discussed in more detail in section 4.5. 
Figure 4.10 D. melanogaster Tip60 chromodomain crystals produced from optimization.  All 
images shown were captured at 4X magnification.  The chromodomain was concentrated to 2.5 
mg/mL and the hanging drop vapour diffusion method was used.  Each droplet was composed of 
1 µL protein solution and 1 µL precipitant solution.  The precipitant solution for all droplets 
pictured was composed of 0.1 M phosphate-citrate at varying pH’s, 0.2 M NaCl, 10 % MPD, and 
PEG8000 at varying concentrations.  A. The droplet condition used pH 5.0 and 24 % PEG8000.  
B. The droplet condition used pH 4.6 and 22 % PEG8000.  C. The droplet condition used pH 5.0 
and 20 % PEG8000.  D. The droplet condition used pH 5.4 and 18 % PEG8000. 
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The co-crystallization of the D. melanogaster Tip60 chromodomain with a peptide 
derived from the N-terminal tail sequence of the histone H3 was also attempted.  Previously 
published research stated that the Tip60 chromodomain was able to bind to the N-terminal tail 
sequence of histone H3 at a mono-methylated lysine 4 (H3K4Me1) (Jeong et al., 2011).  Based 
on this study, the co-crystallization was attempted to elucidate the structural basis of binding.  As 
outlined in section 3.5.1, several sparse matrix screening kits were used to probe for the ideal co-
crystallization conditions.  However, the criteria for the selection of crystals for optimization 
required the crystals have either a different morphology than those found to produce crystals of 
the apo-form of the protein or conditions which produced co-crystals but not apo-protein crystals.  
The rationale for this was that, due to the way the apo-protein packs within the crystal (described 
in detail in section 4.5), it was likely that if the H3K4Me1 peptide bound the protein it would alter 
the crystal packing. 
The sparse matrix screens revealed that the majority of conditions produced crystals 
similar in morphology to the apo-protein.  This indicated there was a high likelihood that those 
crystals would not contain the bound H3K4Me1.  However, there was one condition which 
produced crystals with a different morphology when compared to the apo-protein crystals.  This 
condition was composed of 4.0 M sodium formate and was selected for optimization.  To probe 
the crystallization space around this condition, the concentration of sodium formate was varied.  
Additionally, other formates such as magnesium formate and ammonium formate, were also 
screened.  What was found was that the initial sodium formate condition could not reproduce 
crystals.  However, it was found that the ammonium formate conditions were able to form very 
long and thin needle-like crystals (Figure 4.11).  The production of large singular co-crystals has 
proven to be very difficult to date, therefore further optimization would be required.  Furthermore, 
based on the results of the binding studies discussed in section 4.6, co-crystallization trials with 
H4 peptides will have be done as well. 
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4.5 Crystal structure of the Drosophila melanogaster Tip60 chromodomain 
The crystallization condition composed of 0.1 M phosphate-citrate (pH 4.6), 0.2 M NaCl, 
10 % MPD, and 22 % PEG8000 was found to give the best diffracting crystal.  The crystal was 
diffracted at the Canadian Light Source (CLS) with the bending magnet beamline and data 
collected to 1.59 Å resolution.  The crystal was found to have a space group of P21212 and unit 
cell parameters a = 64.812 Å, b = 68.207 Å, c = 38.313 Å, α = β = γ = 90°.  The data collection 
statistics are reported in Table 4.2. 
Figure 4.11 Potential co-crystal of the D. melanogaster Tip60 chromodomain with the H3K4Me1 
peptide.  The image was captured with 4X magnification.  The chromodomain was concentrated 
to 2.5 mg/mL and the peptide was incubated with the protein in a 2:1 peptide:protein ratio.  
Hanging drop vapour diffusion was used where each droplet was composed of 1 µL protein-
peptide solution and 1 µL precipitant solution.  This condition was composed of 4 M NH4 
formate. 
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Table 4.2 Data collection statistics. 
Values in parentheses are for highest resolution shell.  
*Rmerge= ΣhklΣi|Ii(hkl) - <I(hkl)>|/ ΣhklΣi Ii(hkl) 
X-ray source Bending Magnet 
Wavelength (Å) 1.03320 
Space group P21212 
Unit-cell parameters (Å, °) a=64.812, b=68.207, c=38.313, α=β=γ=90 
Resolution range (Å) 46.98 – 1.596 (1.653 – 1.596) 
Observed reflections 141096 
Unique reflections 23143 (2176) 
Multiplicity 7.1 (5.6) 
Completeness (%) 99.59 (96.20) 
Rmerge
* (%) 4.7 (23.2) 
Rwork 0.1835 (0.2292) 
Rfree 0.2084 (0.3040) 
<I/σ(I)> 41.78 (6.72) 
Number of non-hydrogen atoms 1309 
macromolecules 1182 
water 127 
Protein residues 141 
RMS (bonds) 0.013 
RMS (angles) 1.32 
Ramachandran favored (%) 100 
Ramachandran outliers (%) 0 
Clashscore 1.99 
Average B-factor 17.70 
macromolecules 17.10 
solvent 23.70 
 
The crystal structure was solved by molecular replacement as described in section 3.6.2.  
The solution found by molecular replacement revealed that the asymmetric unit contained two 
copies of the chromodomain.  Previously, it was determined by size-exclusion chromatography 
that the chromodomain was a monomer, which indicated that the two copies found in the 
asymmetric unit associate with one another at least partly due to crystal packing.  Therefore, it 
was possible to examine each copy of the chromodomain in the asymmetric unit individually to 
determine its features and potential binding site, because it was expected that the protein existed 
in solution as a monomer. 
The final model was determined through iterative refinements using the PHENIX 
refinement program (Adams et al., 2010).  The final model of the chromodomain crystal structure 
is shown in Figure 4.12.  Within the final model of the crystal structure, two distinct copies of 
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the chromodomain are found.  When the two copies of the chromodomain were overlaid upon 
each other, it was found the two copies had a root-mean-square deviation (r.m.s.d.) of 0.49, with 
the only significant differences between the two being the conformations of some of the side 
chains.  It was revealed that the chromodomain was composed of four β-strands, two truncated 
α-helices, and loops connecting the β1-β2 strands and β3-β4 strands (Figure 4.12).  The four 
curved β-strands were found to form a β-barrel, the truncated α1 helix was found to be located 
within the β3-β4 loop, and the C-terminal α2 helix was found to form after the β4 strand.  Further 
examination of the final model also revealed that the α2 helix of one of the chromodomain copies 
packs against the curved surface formed by β-strands 2 – 4. 
Within the final model, it was found that the electron density was missing for several side 
chains and terminal backbone residues.  This resulted in those amino acids missing side chain 
density to be left as alanine residues, while residues missing backbone density were omitted from 
Figure 4.12 Cartoon representation of the D. melanogaster Tip60 chromodomain crystal 
structure.  The structure was solved to a resolution of 1.59 Å.  Two copies of the chromodomain 
were found in the asymmetric unit and are shown here.  Both Chain A (green) spans residues 19-
88 and Chain B (cyan) spans residues 19-85.  The secondary structure elements and the N and C 
terminus for both copies of the chromodomain are labeled. 
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the final model.  The rationale behind these omissions was that without electron density it was 
impossible to indicate with confidence the orientation of side chains or terminal residues.  
Additionally, the reason that electron density for these side chain and terminal backbone residues 
were missing was likely due to a high level of mobility within the crystal.  The differences 
between the known D. melanogaster Tip60 chromodomain sequence and the model are 
summarized in Table 4.3. 
As previously mentioned, the Tip60 chromodomain shares 45% sequence identity with 
the MOF chromodomain.  This high level of sequence conservation results in the chromodomains 
adopting a similar structure, as it was found that the MOF chromodomain was composed of five 
β-strands and one C-terminal α-helix (Figure 4.13A).  The structural similarities are easily 
visualized when the two structures are superimposed upon one another (Figure 4.13B).  
Furthermore, based on unpublished data from the Moore lab of the MOF chromodomain, it was  
Table 4.3 Differences between dTip60 chromodomain sequence and final model 
Chain ID Residue in dTip60 sequence Residue in model Comments 
A N/A Leu3 Part of fusion protein linker 
A N/A Gly4 Part of fusion protein linker 
A N/A Ser5 Part of fusion protein linker 
A Glu49 Glu49 Alternate conformation 
A Lys80 Ala80 No side chain density 
A Arg86 Ala86 No side chain density 
A Asp87 Ala87 No side chain density 
A Gly88 N/A No backbone density 
B N/A Ser5 Part of fusion protein linker 
B Glu49 Glu49 Alternate conformation 
B Lys80 Ala80 No side chain density 
B Arg85 Ala85 No side chain density 
B Arg86 N/A No backbone density 
B Asp87 N/A No backbone density 
B Gly88 N/A No backbone density 
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proposed that the peptide binding groove was located between the β1-β2 loop and the β3-β4 loop 
(Figure 4.13B).  Due to the structural similarities between Tip60 and MOF, it is likely that this 
location in Tip60 could bind substrates as well. 
Previously published data suggested that the Tip60 chromodomain residues Trp39, 
Phe56, and Tyr60 (equivalent to residues Trp26, Phe43, Tyr47 in the H. sapiens Tip60 
chromodomain) were involved in the formation of an aromatic cage proposed to be a 
methyllysine binding site (Jeong et al., 2011; Sun et al., 2009).  However, the crystal structure 
revealed that the formation of this specific aromatic cage was not possible (Figure 4.14).  The 
reason for this was that it was found that Phe56 was actually buried and not solvent accessible, 
rendering it unable to contribute to binding.  Furthermore, Trp39 and Tyr60 were found to be 
positioned away from each other and unlikely to contribute together towards the formation of a 
binding site.  As previously mentioned, the peptide binding groove was thought to be located 
between the β1-β2 loop and the β3-β4 loop.  The crystal structure revealed that, of the three 
residues originally proposed to form an aromatic binding cage (Trp39, Phe56, Tyr60), only Tyr60 
was located within the proposed peptide binding groove (Figure 4.14).  Additionally, it was found 
Figure 4.13 Structure of MOF chromodomain.  A. The unpublished crystal structure of the D. 
melanogaster MOF chromodomain.  The chromodomain was composed of five β-strands and 
one C-terminal α-helix.  B. An overlay of the MOF chromodomain (magenta) with the D. 
melanogaster Tip60 chromodomain (green).  The proposed peptide binding groove in MOF was 
thought to be located between the β1-β2 loop and the β3-β4 loop. 
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that Trp39 was located on the β1-β2 loop and that its side chain was positioned on the outer 
surface of the chromodomain.  Although the residues Trp39, Phe56, and Tyr60 do not bind 
methyllysine through the aforementioned mechanism, it was found that Trp39 and Tyr60 may be 
located at separate potential binding sites (Figure 4.15). 
The first potential binding site found in the chromodomain crystal structure was 
composed of residues Trp39 and Tyr77.  The crystal structure revealed that Trp39 was located in 
the β1-β2 loop and Tyr77 was located following the α2-helix.  Additionally, it was found that 
these two residues were located on one of the crystal contact surfaces, which indicated that these 
residues were buried in the crystal structure.  It was found that due to crystal packing the Lys48 
residue of one chromodomain molecule would pack between the Trp39 and Tyr77 of another 
chromodomain molecule (Figure 4.15A).  The presence of a Lys residue between these two 
aromatic residues suggested this site could serve as a potential location for the binding of 
methyllysine.  Although this surface was buried in the crystal structure, the data obtained from 
Figure 4.14 Previously proposed residues for methyllysine binding.  The three aromatic residues, 
Trp39, Phe56, and Tyr60, previously proposed to form the methyllysine binding pocket are 
shown in yellow.  The chromodomain was rotated 90° counterclockwise to give a better view of 
how the three residues were oriented.  The three residues do not form the proposed methyllysine 
binding pocket.  It was found that Trp39 was located on the β1-β2 loop and its side chain was 
positioned on the outer surface of the chromodomain.  The Tyr60 residue was found to be located 
at the base of the proposed peptide binding groove.  Finally, Phe56 was found to be buried within 
the core of the protein and unlikely to be involved with binding. 
76 
 
the size-exclusion chromatography experiments indicated that the chromodomain exists as a 
monomer in solution and, therefore, indicated that this surface was potentially available for 
peptide binding.   
Figure 4.15 Potential methyllysine binding sites.  A. Close up view of a potential binding pocket 
formed by Trp39 and Tyr77.  Circled here are a ball and stick representation of Lys48 (yellow) 
located on Chain A (green), Trp39 and Tyr77 (magenta) located on Chain B (cyan).  Due to 
crystal packing Lys 48 of Chain A sits between Trp39 and Tyr77 of Chain B, which indicates a 
potential methyllysine binding site.  B. Close up view of the potential binding pocket formed by 
Tyr60 and Phe63.  The ball and stick representation of Tyr60, Phe63, and Met33 (magenta) are 
circled.  The two aromatic residues were found to be located within the proposed peptide binding 
groove.  However, the position of Met33 blocks access to the substrate binding groove. 
77 
 
However, when examining a sequence alignment between the D. melanogaster Tip60 
chromodomain with other MYST chromodomain homologs it was found while Trp39 was highly 
conserved, the tyrosine residue was only found in the D. melanogaster Tip60 chromodomain 
(Figure 4.16).  The lack of sequence conservation at the tyrosine residue could be seen as an 
indicator that this site does not bind methyllysine.  It should be noted, however, that, although 
this site was unlikely to bind methyllysine in the D. melanogaster Tip60 homologs, it was 
possible that this location could serve as a unique binding site specific only to D. melanogaster. 
The second potential binding site revealed by the crystal structure contained residues 
Tyr60, Phe63, and Met33 (Figure 4.15B).  As previously discussed, it was proposed that the 
peptide binding groove was positioned between the β1-β2 loop and β3-β4 loop.  The crystal 
structure showed that the Met33 residue was located on the β1-β2 loop, the Phe63 residue was 
located on the β3-β4 loop, and the Tyr60 residue was located at the floor of the proposed peptide 
binding groove.  The presence of these two aromatic residues in the proposed binding groove 
indicated this location was a possible methyllysine binding site.  However, the position of Met33 
in the D. melanogaster Tip60 chromodomain would block substrate binding unless it was flexible 
enough to undergo a conformational change.  An alignment of the Tip60 chromodomain with 
other chromodomain containing MYST proteins revealed that the Tyr60 residue was strictly 
conserved across the MYST family (Figure 4.16).  Furthermore, the sequence alignment revealed 
that other members of the MYST family contained an aromatic residue at the equivalent position 
as Phe63 and that the Met33 residue was poorly conserved (Figure 4.16). 
 
78 
 
As previously stated, the position of Met33 would block substrate binding, unless it was 
able to undergo a conformational change.  To asses the flexibility of Met33 within the crystal 
structure, it was necessary to examine the B-factors (also known as the temperature factors), 
which described the displacement from the average atomic position in square angstroms (Å2).  
This value was assigned to each atom in the crystal structure.  Therefore, if the Met33 side chain 
was flexible the B-factor values of the side chain atoms were expected to be high.  The B-factors 
for the Met33 side chain ranged from 12-17 Å2.  This indicated that the side chain atoms were 
inflexible within the crystal structure.  This apparent rigidity in Met33 indicated two possibilities: 
in solution, the chromodomain exhibited this rigidity and, therefore, substrate binding at this site 
could only be achieved if a major conformational change occurred, or the second possibility was 
that this rigidity, seen in the crystal structure, was simply an artefact of crystal packing.  If the 
second possibility were found to be true and Met33 and its surrounding residues were flexible, it 
would be likely that in the presence of substrate Met33 could move away from the binding pocket. 
The final site of interest in the crystal structure of the chromodomain contained residues 
His59 and Asp68.  The crystal structure revealed that the His59 residue was located on the C-
terminal end of the β3 strand and the Asp68 residue was located on the β3-β4 loop (Figure 4.17).  
Figure 4.16 Sequence alignment of the chromodomain containing MYST proteins.  The residues 
highlighted in red show strict sequence identity whereas those residues highlighted in yellow and 
bolded show sequence similarity.  Sequence alignment was generated using clustal omega 
(Goujon et al., 2010; Sievers et al., 2011).  Asterisks correspond to residues found in D. 
melanogaster Tip60 chromodomain discussed in this section. * - Met33, * - Trp39, * - His59 and 
Asp68, * - Tyr60, * - Phe63, * - Tyr77. 
79 
 
Examining the crystal structure revealed that His59 and Asp68 formed a hydrogen bond with a 
distance of 2.7 Å.  Based on this distance, it was likely that the two residues were able to form a 
salt bridge as well.  The salt bridge interaction is defined as the combination of two non-covalent 
interactions: the hydrogen bond and an electrostatic interaction (Bosshard et al., 2004).  
Therefore, at physiological pH, it would be possible for His59 and Asp68 to form a salt bridge, 
due to the presence of a partial positive charge on His59 and the negative charge on Asp68.  Due 
to the position of both residues, it could be possible that the salt bridge formed aids in the 
stabilization of the β3-β4 loop structure.  Additionally, a sequence alignment amongst the 
chromodomain containing MYST family members revealed that both the histidine and aspartate 
residues were strictly conserved among all MYST chromodomains (Figure 4.16). 
The conservation of this His-Asp pair were found to extend into other chromodomains, 
such as those found in MSL3 (Figure 4.18A).  Previously, it had been reported that 
chromodomains belonging to MSL3 (Kim et al., 2010) and members of the MYST family such 
as Esa1 (Shimojo et al., 2008) and MOF (Conrad et al., 2012) were able to contact nucleic acids.  
From the crystal structure of MSL3, it could be seen that the His-Asp pair formed a salt bridge 
with the phosphate backbone of duplex DNA (Figure 4.18B).  An overlay of MSL3 with the 
Tip60 chromodomain revealed structural similarity between the two chromodomains and 
highlighted conservation and positions of the His-Asp pair relative to the DNA backbone (Figure 
4.18B).  Due to the strict conservation of this His-Asp pair across chromodomains and its ability 
to contact the phosphodiester backbone of duplex DNA in MSL3, it is possible that these amino 
acids play a role in the interaction and/or recognition of nucleosomal DNA. 
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Figure 4.17 Structural view of the strictly conserved His-Asp pair.  Circled here are a ball and 
stick representation of Asp68 and His59 (yellow) in relation to the entire chromodomain (shown 
as a cartoon coloured green).  An enlarged view of the two residues showed that a hydrogen bond 
of 2.7 Å is formed between histidine and aspartate (magenta dashes).  At physiological pH, it 
would be possible for these residues to form a salt bridge, as in addition to the hydrogen bond, 
the partial positive charge found on the His residue would interact with the negative charge of 
the Asp residue as well.  The His residue could potentially be involved in contacting the 
phosphate backbone of duplex DNA through a salt bridge. 
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Figure 4.18 Comparison of MYST chromodomains with the MSL3 chromodomains.  A. 
Sequence alignment of the MYST chromodomains with MSL3 chromodomains.  The alignment 
found that the D. melanogaster Tip60 residues His59 and Asp68 were strictly conserved amongst 
all MYST and MSL3 chromodomains (both residues highlighted in red).  B. An overlay of the 
D. melanogaster Tip60 chromodomain (cyan) with H. sapiens MSL3 (red) (PDB ID: 3OA6).  
The duplex DNA (orange) is also shown interacting with MSL3.  An enlarged view of the 
conserved His-Asp pair showed that MSL3’s Asp64 (yellow) was within 2.8 Å of His55 (yellow) 
to form a hydrogen bond or salt bridge.  It was also found that MSL3’s His55 residue was 
positioned 2.8 Å from the phosphodiester backbone of DNA, which allowed it to form a hydrogen 
bond or salt bridge with DNA.  The overlay also showed that Tip60’s His 59 (magenta) would 
be in a position to contact duplex DNA as well. Note that in the MSL3 crystal structure, it contacts 
a second DNA molecule, only one is shown here. 
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The high resolution structure of the D. melanogaster Tip60 chromodomain allowed for 
the identification of two potential methyllysine binding sites.  The first potential binding site 
involved residues Trp39 and Tyr77, which were found to be located on the outer surface of the 
chromodomain.  However, due to poor sequence conservation of the Tyr77 across MYST 
chromodomains, it was unlikely that this was the primary location for methyllysine binding.  It 
could be possible that the Trp39 and Tyr77 site is unique to the D. melanogaster Tip60 
chromodomain.  The second potential methyllysine binding site was composed of residues Tyr60 
and Phe63, which were found to be located in the proposed peptide binding groove located 
between the β1-β2 loop and the β3-β4 loop.  Furthermore, a sequence alignment of MYST 
chromodomains showed the strict conservation of residue Tyr60 and that an aromatic residue was 
present at the equivalent position of Phe63.  Finally, it was found that His59 and Asp68 were 
located on the β3 strand and β3-β4 loop respectively.  These two residues were found to interact 
through a hydrogen bond and were likely to form a salt bridge at physiological pH.  Additionally, 
a sequence alignment revealed that this His-Asp pair was strictly conserved across all MYST and 
MSL3 chromodomains.  Furthermore, an overlay with an MSL3 crystal structure complexed with 
duplex DNA indicated that this His-Asp pair was likely involved in contacting the phosphodiester 
backbone of DNA.  These insights formed the foundation for identifying the structural basis of 
binding of the Tip60 chromodomain to its partners.  Before attempting to determine the structural 
basis of binding, several experiments were done to elucidate and confirm the binding partners of 
the Tip60 chromodomain. 
4.6 Binding Studies between Drosophila melanogaster Tip60 chromodomain and histone 
peptides 
4.6.1 Aggregation of Drosophila melanogaster Tip60 chromodomain during recording of 1H–
15N HSQC spectra 
The NMR study of the D. melanogaster Tip60 chromodomain was unable to produce 
results as the protein aggregated during data collection (Figure 4.19).  This was likely due to the 
buffer the protein was stored in during data collection.  Previously, it was found that the D. 
melanogaster Tip60 chromodomain was most soluble at pH 9.5, several pH units away from its 
pI of 6.06, and that the protein was insoluble in most buffers with a pH range of 6.0 – 8.5.  To 
collect good HSQC spectra, the protein was required to be solubilized in a buffer composed of 
40 mM phosphate buffer pH 7.5, 50 mM NaCl, and 5 % MPD.  Due to the pH of the phosphate 
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buffer, it was likely that the long term storage of the protein was not possible, which resulted in 
the precipitation and aggregation of the chromodomain. 
 
Figure 4.19 HSQC spectra for D. melanogaster Tip60 chromodomain.  The HSQC spectra for 
the Tip60 chromodomain showed that many of the peaks had clustered.  This indicated that the 
protein aggregated during the measurement of the HSQC spectra.  The y-axis shows 15N 
measurement and the x-axis shows the proton chemical shifts in parts per million (ppm). 
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4.6.2 Surface plasmon resonance revealed interaction between histone H4 peptides and 
Drosophila melanogaster Tip60 chromodomain 
There were several candidates which were identified as potential substrates for the D. 
melanogaster Tip60 chromodomain.  These candidates were peptide sequences derived from 
either the N-terminal tail sequence of histone H3 or H4 and typically contained a distinctly 
modified lysine residue, which corresponded to a post-translational modification involved with 
gene regulation.  To rapidly screen this peptide library, surface plasmon resonance (SPR) was 
utilized.  The SPR experiments were conducted at the Saskatchewan Structural Sciences Centre 
and utilized the ProteOn XPR36 protein interaction array system from BioRad. 
As described in section 3.7.2, the chromodomain was covalently linked to the 
carboxylated alginate polymer surface of a sensor chip (GLM, Bio-Rad) through amine coupling.  
Based on this immobilization procedure, 25 µg/mL of the D. melanogaster Tip60 chromodomain 
resulted in approximately 2200 RU of the chromodomain immobilized onto the sensor chip.  
Additionally, for the initial screening of the peptide library, the D. melanogaster MOF 
chromodomain was used as a control due to it sharing 45% sequence identity with Tip60 and 
because the Moore lab had previously elucidated its binding partners.  For the immobilization of 
the MOF chromodomain, 20 µg/mL was incubated with an immobilization buffer composed of 
10 mM sodium acetate at pH 4.5.  This resulted in 3000 RU of the MOF chromodomain to be 
immobilized onto the sensor chip.  This level of protein density on the surface of the sensor chip 
was found to give the optimal response for the detection of protein-peptide interactions for this 
specific system. 
The 6 x 6 interaction array system allowed for the Tip60 chromodomain and MOF 
chromodomain to be immobilized in parallel and the peptide library to be screened against both 
chromodomains simultaneously.  As described in section 3.7.2, the initial screening procedure 
used a fixed concentration of 100 µM for each peptide to quickly assess which of the peptides 
interacted with the chromodomains.  This initial group of peptides screened reflected those which 
corresponded to the sequences found on the N-terminal tails of either histone H3 or H4 and are 
listed in Table 4.4. 
85 
 
Table 4.4 Peptides used in SPR experiments 
Histone Tail 
Peptide 
N/C 
Terminus 
Sequence Molecular 
Weight 
(Da) 
*^H46-24 Unmodified H/NH2 GGKGLGKGGAKRHRKVLRDY 2153 
*^H4K12Ac NH2/Amide GGKGLG(KAc)GGAKRHRKVLRDY 2195 
*^H4K16Ac NH2/OH GGKGLGKGGA(KAc)RHRKVLRDY 2195 
*^H4K20Me1 NH2/Amide GGKGLGKGGAKRHR(KMe)VLRDY 2166 
*^H4K20Me3 Ac/Amide GAKRHR(KMe3)VLRDNY 1698 
^H3K4Me1 Ac/Amide ART(KMe)QTARKSTGGY 1579 
^H3K9Me3 Ac/Amide KQTAR(KMe3)STGGY 1281 
H3K27Me3 Ac/Amide SKAAR(KMe3)SAPAY 1234 
H3K36Me1 Ac/Amide STGGV(KMe)KPHRY 1284 
^H3K36Me3 Ac/Amide STGGV(KMe3)KPHRY 1314 
H49-15 NH2/Amide GLGKGGAY 721 
*^H416-20 NH2/Amide KRHRKY 886 
H420-24 NH2/Amide KVLRDNY 793 
*H4D24K NH2/Amide HRKVLRKNY 1212 
#H4K20 short Ac/Amide YGAKRHRKV 1155 
#H4R17A Ac/Amide YGAKAHRKV 1070 
#H4R17E Ac/Amide YGAKEHRKV 1128 
#H4H18A Ac/Amide YGAKRARKV 1089 
#H4H18E Ac/Amide YGAKRERKV 1147 
#H4R19A Ac/Amide YGAKRHAKV 1070 
#H4R19E Ac/Amide YGAKRHEKV 1128 
* - denotes positive hits from initial SPR screening 
^ - denotes peptides used for steady state affinity experiments 
# - denotes H414-21 tail peptides used for identifying key residues for binding 
The screening process found several peptide sequences derived from the histone H4 N-
terminal tail that interacted with the Tip60 chromodomain (Table 4.4).  It was also found that 
those peptides which the Moore lab had previously determined to interact with the MOF 
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chromodomain also exhibited an interaction during the screening process.  This was important 
for two reasons: the first reason was that it confirmed that the ProteOn XPR36 protein interaction 
array system worked, the second reason was that, due to sharing 45% sequence identity with the 
MOF chromodomain, it was expected the Tip60 chromodomain would have similar binding 
partners.  The screening process also revealed that many of the peptides derived from the N-
terminal tail sequence of histone H3 did not show any interaction or showed a relatively weak 
interaction.  This data allowed for the selection of peptides, which would be used in titration 
experiments to determine the binding affinity.  Additionally, the binding affinity of the Tip60 
chromodomain for the H3 peptides was also determined as these peptides had previously been 
reported (Jeong et al., 2011; Sun et al., 2009) to bind the Tip60 chromodomain.  The titration of 
these peptides was outlined in section 3.7.2. 
The steady state affinity experiments utilized ten different peptide concentrations, which 
allowed for the dissociation constant (KD) to be determined.  These concentrations were 
dependent upon the results of the initial screening process.  For the H4 peptides, which appeared 
to show an interaction with the Tip60 chromodomain at 100 µM, the concentrations used were 
as follows: 300 µM, 150 µM, 100 µM, 50 µM, 33.3 µM, 16.7 µM, 11.1 µM, 5.55 µM, 3.7 µM, 
and 1.85 µM.  The H3 peptides, which showed minimal to no interaction at 100 µM, required 
that the steady state affinity experiment be performed with a higher concentration range (1 mM, 
500 µM, 333 µM, 167 µM, 111 µM, 55.6 µM, 37 µM, 18.5 µM, 12.3 µM, and 6.17 µM).  The 
peptides used for the steady state experiment are listed in Table 4.4.   
The RUs for each interaction were recorded and the sensorgrams for each interaction with 
the H4 peptides are shown in Figure 4.20; the interactions with H3 peptides are shown in Figure 
4.21.  However, close examination of the raw sensorgrams revealed a high background signal for 
all peptides and a signal-to-noise of 1.3 (Figure 4.22).  It was found that the reference channel, 
which does not have protein bound but underwent the same activation/deactivation process, 
showed a high signal in response to the peptide flowing over the channel.  This indicated the 
presence of non-specific binding of the peptides to the sensor chip surface.  The reason for this 
non-specific binding could be attributed to the positive charge the peptides carried and the 
negative charge found on the sensor chip surface.  However, even with the presence of non-
specific binding, several of the peptides (specifically H46-24 unmodified, H4K12Ac, H4K16Ac, 
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and H4K20Me1) possessed the same sequence and charge, yet exhibited different binding 
profiles.  This indicated that the interaction observed between the peptides and the Tip60 
chromodomain were likely to be real, but further binding studies would need to be conducted to 
confirm and quantify the interaction. 
 
Figure 4.20 SPR sensorgrams for each H4 peptide interaction.  The sensorgrams measured the 
response detected over time for a given concentration of peptide.  The signal detected for each 
concentration is shown in the graph as coloured peaks.  The peaks in each graph, in descending 
order, correspond to the following concentration: 300 µM, 150 µM, 100 µM, 50 µM, 33.3 µM, 
16.7 µM, 11.1 µM, 5.55 µM, 3.7 µM, and 1.85 µM.  Additionally, the reference channel signals 
have been subtracted from the sensorgrams shown here.  Note that the y-axis scale for each graph 
is different. 
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From the steady state affinity experiments, it was possible to determine an approximate 
KD value for each peptide.  First, the values were normalized according to Equation 3.2, which 
was previously described in section 3.7.2 and these normalized values were plotted against the 
concentration of the peptide.  The purpose of the normalization procedure was to allow for the 
accurate comparison of the different peptides (Davis and Wilson, 2000).  The normalized data 
for the H4 and H3 peptides was fitted independently in Origin (from OriginLab) to produce the 
Rmax and KD values.  It should be noted that for the H3 peptides, a reasonable Rmax or KD value 
could not be calculated, as the binding site could not be saturated.  The reason that the H3 peptides 
were not able to saturate the binding site was likely due to the very weak nature of the binding, 
therefore the peptide concentration required to saturate the binding site would have to be much 
higher.  This revealed that the Tip60 chromodomain showed a minimal interaction with the H3 
Figure 4.21 SPR sensorgrams for each H3 peptide interaction.  The sensorgrams measured the 
response detected over time for a given concentration of peptide.  The signal detected for each 
concentration is shown in the graph as coloured peaks.  The peaks in each graph, in descending 
order, correspond to the following concentration: 1 mM, 500 µM, 333 µM, 167 µM, 111 µM, 
55.6 µM, 37 µM, 18.5 µM, 12.3 µM, and 6.17 µM.  Additionally, the reference channel signals 
have been subtracted from the sensorgrams shown here.  Note that the y-axis scale for each graph 
is different. 
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peptides and instead, preferentially bound to the H4 peptides (Figure 4.23, Table 4.5).  The 
difference in Rmax between the H4 peptides could be attributed to several possibilities, such as 
the difference in molecular weight between the peptides or the degradation and/or unfolding of 
the immobilized chromodomain.  The Tip60 chromodomain appeared to prefer binding the 
H4K20Me1 (KD of 8.8 µM), H46-24 Unmodified (KD of 12 µM), and H4K12Ac (KD of 21 µM) 
peptides.  Additionally, a weaker interaction was observed with H4K16Ac (KD of 140 µM).  The 
sequence length and charge of these four peptides were found to be very similar, the major 
difference between each was the type and location of the modified lysine residue, with each 
exhibiting a different level of interaction with the chromodomain.  Furthermore, the H4-short 
sequence (KRHRKY) which corresponded to the residues between H4K16 and H4K20, exhibited 
an interaction with the Tip60 chromodomain.  This indicated that it was possible that at least one 
of the three residues between H4K16 and H4K20 was integral for binding to the Tip60 
chromodomain. 
 
Figure 4.22 Raw SPR sensorgrams for the histone peptides.  The sensorgrams corresponding to 
the reference channel (top left) and the channel with the immobilized Tip60 chromodomain (top 
right) are shown.  The signal recorded by the reference channel indicated that background noise 
of SPR experiments were very high.  The bottom panel shows the signal of the interaction 
between the protein and peptide after the background signal was subtracted.  Note that the y-axis 
scale for each graph is different. 
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Figure 4.23 SPR steady state titrations of histone tail peptides with D. melanogaster Tip60 
chromodomain.  The H4 and H3 peptides were fitted independently to determine the Rmax and 
KD for each peptide.  As the binding of the H3 peptides does not saturate the binding site, it was 
not possible to calculate the Rmax or KD for these peptides.  The inability of the H3 peptides to 
saturate the binding site could be attributed to the very weak nature of the binding interaction. 
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Table 4.5 Calculated Rmax and KD for H4 and H3 peptides 
Peptide Rmax Standard Error 
for Rmax 
KD (M) Standard Error 
for KD (M) 
H46-24 Unmodified 0.76 0.02 1.2 x 10
-5 1.4 x 10-6 
H4K12Ac 0.51 0.01 2.1 x 10-5 1.8 x 10-6 
H4K16Ac 0.43 0.02 1.4 x 10-4 1.1 x 10-5 
H4K20Me1 0.37 0.01 8.8 x 10
-6 1.2 x 10-6 
H4K20Me3 0.61 0.09 6.1 x 10
-4 1.2 x 10-4 
H4-Short (KRHRKY) 0.62 0.04 2.8 x 10-5 5.6 x 10-6 
#H3K4Me1 N/A N/A N/A N/A 
#H3K9Me3 N/A N/A N/A N/A 
#H3K36Me3 N/A N/A N/A N/A 
* - denotes estimated value 
# - denotes peptides which did not saturate binding site therefore Rmax and KD could not be 
calculated 
To determine which of the three residues between H4K16 and H4K20 was integral for 
binding, short H4 peptides with either an alanine or glutamate mutation to one of the three 
residues were examined (Table 4.4).  The glutamate mutations were expected to cause a greater 
disruption to the binding than the alanine mutations, due to the reduction of the overall positive 
charge of the peptide caused by the replacement with the glutamate residue.  It was expected that, 
if one the three residues between H4K16 and H4K20 was integral to binding, then a mutation to 
that residue would cause a decrease in the KD as determined by a steady state affinity experiment. 
The steady state affinity experiment confirmed that the glutamate mutations, H4R17E, 
H4H18E, and H4R19E caused a severe disruption to the binding, as the response observed was 
near to the baseline.  The glutamate mutations were also found to reduce the overall positive 
charge of the peptide, which could disrupt any potential ionic interactions with the chromodomain 
or the sensor chip surface, resulting in a near baseline response.  It was also found that the three 
alanine mutations, H4R17A, H4H18A, and H4R19A were able to disrupt the binding of the 
peptides to the Tip60 chromodomain (Figure 4.24).  It was not possible to determine the Rmax or 
KD for any of the mutant peptides, as none of the peptides were able to saturate the binding site 
(Figure 4.24, Table 4.6).  The inability to saturate the binding site could be attributed to the 
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concentrations utilized in the titrations being significantly lower than the expected KD.  To 
reasonably estimate the Rmax and KD of the mutant peptides, higher concentrations will have to 
be used in the titrations.  When compared to the wild type sequence, the mutations to Arg17, His 
18, and Arg19 clearly showed that the binding of the peptide to the chromodomain was disrupted, 
which indicated that at least one of these residues could be involved in interacting with the Tip60 
chromodomain. 
 
 
Figure 4.24 SPR steady state titrations of the mutant H414-21 tail peptides.  Titrations were 
performed using peptide concentration ranges between 300 µM and 1.85 µM.  The WT H4K20 
(YGAKRHRKV) peptide was fitted independently to approximate the Rmax and KD values.  It 
should be noted that it was not possible to reasonably estimate the Rmax and KD values for the 
mutant H4 peptides as the binding site could not be saturated. 
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Table 4.6 Calculated KD for H4 mutant peptides 
Peptide KD (M) Standard Error for KD (M) 
H4K20 (YGAKRHRKV) 1.3 x 10-4 7.5 x 10-6 
H4R17A N/A N/A 
H4R17E N/A N/A 
H4H18A N/A N/A 
H4H18E N/A N/A 
H4R19A N/A N/A 
H4R19E N/A N/A 
 
The SPR data revealed that the D. melanogaster Tip60 chromodomain preferentially 
interacted with peptides corresponding to residues 6 – 24 found in the N-terminal tail sequence 
of histone H4.  Additionally, it appeared as though the chromodomain specifically interacted with 
a specific region within the H4 tail sequence.  The SPR binding data suggested that the Tip60 
chromodomain interacted with the H4 tail sequence between residues 16 – 20.  Through the use 
of point mutations to residues Arg17, His18, and Arg19, it was determined that at least one of 
the three residues were integral for binding to the Tip60 chromodomain; as mutations to these 
residues showed a significant decrease in binding when compared to the wild type sequence.  The 
interaction between the Tip60 chromodomain and the H4 peptides was then validated by 
isothermal titration calorimetry.  
4.6.3 Interaction between Drosophila melanogaster Tip60 chromodomain and histone H4 
peptides confirmed by isothermal titration calorimetry 
To confirm the binding data results of the D. melanogaster Tip60 chromodomain and the 
H4 peptides obtained from SPR, isothermal titration calorimetry was used.  These experiments 
were conducted at Protein Characterization and Crystallization Facility at the University of 
Saskatchewan with the Nano-ITC instrument from TA Instruments.  The standard control 
experiment that utilized 1,4,7,10,13,16-hexaoxacyclooctadecane (18-crown-6) and KCl 
(Turnbull and Daranas, 2003) was performed, which ensured proper operation of the ITC 
instrument (Figure 4.25). 
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As described in section 3.7.3, the D. melanogaster Tip60 chromodomain was 
concentrated to 0.34 mM and placed into the reaction cell.  The H413-20 unmodified peptide was 
prepared to a concentration of 6.5 mM and placed in the syringe.  The ITC experiment was 
performed at 25° C, utilized a stir rate of 200 rpm, and 19 injections of 2.5 µL.  The data was 
then analysed with the NanoAnalyze software from TA Instruments. 
The ITC data confirmed the interaction between the Tip60 chromodomain and the H413-
20 unmodified peptide (sequence shown in Table 3.5) (Figure 4.26).  The data was fitted using 
the independent binding model, which found that the KD was 7.3 x 10
-5 M and that the 
stoichiometry of the reaction was n = 3.7; the other statistics determined by the fitting were shown 
in Table 4.7.  It was expected that the binding of the H4 peptide to the chromodomain would 
exhibit 1:1 binding however, the estimated stoichiometry of the reaction was approximately 4:1 
(peptide:chromodomain).  The overestimation of the stoichiometry could be explained by the 
Figure 4.25 Isothermal titration calorimetry analysis of crown ether and KCl.  The top panel 
shows the heat rates for the 21 total injections completed.  The first two injections were not 
included in the fitting process (bottom panel) as the purpose of the first two injections was to 
minimize the equilibration artifacts typically seen at the start of every titration series.  The bottom 
panel plots the integrated heat peaks against the molar ratio of KCl. 
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weak nature of the interaction between the peptide and the Tip60 chromodomain.  Other studies 
have found that, in order to reasonably estimate the stoichiometry of a reaction, the concentration 
of the protein must be at least 10 times greater than the KD (Turnbull and Daranas, 2003).  If the 
concentration of the chromodomain used in these experiments was too close to the actual KD of 
the reaction, the stoichiometry could not be reasonably estimated.  Furthermore, the data showed 
that the reaction was not saturated.  The inability to saturate the binding site could be attributed 
to the dimerization or unfolding of the chromodomain throughout the reaction.  To distinguish 
the difference between structural perturbations and those caused by binding, circular dichroism 
spectroscopy or NMR would have to be performed. 
 
 
Figure 4.26 Isothermal titration calorimetry analysis of the H413-20 unmodified binding to D. 
melanogaster Tip60 chromodomain.  The top panel shows the heat rates for the 21 total injections 
completed.  The first two injections were not included in the fitting process (bottom panel) as the 
purpose of the first two injections was to minimize the equilibration artifacts typically seen at the 
start of every titration series.  The bottom panel plots the integrated heat peaks against the molar 
ratio of the peptide. 
96 
 
Table 4.7 Statistics from ITC bindings experiment 
KD (M) 7.3 x 10
-5 
n 3.7 
ΔH (kJ/mol) -2.4 
ΔS (J/mol K) 71 
 
It was assumed that if the reaction were saturated, it would be possible to elucidate both 
the stoichiometry and strength of the interaction.  Therefore, the ITC experiment was repeated, 
with either more injections of peptides at the same peptide concentration or with the same number 
of injections but a higher concentration of peptide; in both cases, the molar ratio of peptide to 
protein was increased.  However, it was found that these adjustments were not sufficient to result 
in saturation of the binding site. 
The ITC data confirmed that the D. melanogaster Tip60 chromodomain does interact with 
the unmodified H413-20 peptide; however, it was unable to confirm the stoichiometry or KD of the 
interaction due to the inability to saturate the binding site.  This inability to saturate the binding 
site could be attributed to dimerization or unfolding of the chromodomain throughout the 
reaction.  To elucidate these variables, further optimization of the ITC study will be required. 
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5 DISCUSSION 
5.1 Structural comparison of Drosophila melanogaster Tip60 chromodomain to other related 
chromodomains 
The canonical chromodomains, such as HP1, have been found to bind methylated lysine 
residues located on N-terminal histone tails through the presence of an aromatic cage (Blus et al., 
2011).  Previous studies have suggested that the Tip60 chromodomain was able bind methylated 
lysine residues to allosterically regulate its HAT domain (Jeong et al., 2011; Sun et al., 2009).  
Furthermore, these studies attributed this binding to the presence of an aromatic cage and 
identified the residues Trp26, Phe43, and Tyr47 in H. sapiens Tip60 chromodomain to be 
responsible for the formation of this cage.  Additionally, these studies linked the loss of any of 
these three aromatic residues to abrogate binding to methyllysine.  However, studies on the Tip60 
paralog MOF revealed that the chromodomain of MOF does not contain an aromatic cage for 
methyllysine binding (Nielsen et al., 2005).  This was found to be significant as Tip60 and MOF 
share 45% sequence identity, which indicated the two are likely to adopt similar structures. 
This research was able to determine the crystal structure of the D. melanogaster Tip60 
chromodomain, which provided insight as to whether the predicted aromatic cage for 
methyllysine binding was present or not.  The crystal structure revealed that the aromatic residues 
Trp39, Phe56, and Tyr60 (equivalent residues to Trp26, Phe43, and Tyr47 in H. sapiens Tip60 
chromodomain) do not form an aromatic cage as originally proposed by Sun et al. (2009) and 
Jeong et al. (2011).  It was found that Trp39 was positioned on the outer surface of the 
chromodomain, Phe56 was buried within the core the protein, and only Tyr60 was located in the 
proposed peptide binding groove.  Therefore, it was unlikely that the proposed aromatic cage 
could be formed by these three residues.  Moreover, it was not possible to conclusively link the 
loss of binding observed in prior studies to the mutation of one of these three residues.  The loss 
of function that was attributed to the mutation of Trp39, Phe56, and Tyr60, could be caused by 
the misfolding of the protein as opposed to the disruption of the aromatic binding cage. 
The crystal structure of the D. melanogaster Tip60 chromodomain also revealed two 
potential methyllysine binding sites.  One site was found to be formed by Trp39 and Tyr77, while 
the second site was formed by Tyr60 and Phe63.  A sequence alignment of the D. melanogaster 
Tip60 chromodomain with other chromodomain containing MYST HATs found that, of the two 
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potential methyllysine binding sites, only the site composed of Tyr60 and Phe63 showed high 
level of conservation with other chromodomains.  It was found that Tyr60 was strictly conserved 
amongst MYST HAT chromodomains and that an aromatic residue was present at the equivalent 
position of Phe63.  The strict conservation of the Tyr60 was found to be of note, due to the 
suggestion that it was one of the residues responsible for the formation of an aromatic cage (Jeong 
et al., 2011; Sun et al., 2009).  Furthermore, the sequence alignment revealed that a second 
aromatic residue positioned near Tyr60 was present in several MYST HAT chromodomains.  An 
aromatic cage has been previously defined to be composed of two to four aromatic residues 
oriented in a cage-like structure (Musselman et al., 2012).  By this definition, the site composed 
of Tyr60 and Phe63 in the D. melanogaster Tip60 chromodomain was the ideal location for an 
aromatic cage to bind methyllysine.  However, close inspection of this potential binding site 
revealed the Met33 residue blocks access to the aromatic residues.  Therefore, for this region to 
bind substrates, the Met33 residue would have to move away from the potential binding site. 
The sequence alignment of the Tip60 chromodomain with other MYST HAT 
chromodomains and the canonical chromodomain MSL3 revealed a strictly conserved His-Asp 
pair.  Previous studies on MSL3 found that this histidine residue was involved in contacting the 
phosphodiester backbone of DNA (Kim et al., 2010).  Additionally, it has been reported that the 
MYST family members Esa1 and MOF were also able to interact with nucleic acids, although 
the mechanism by which this is achieved has not been confirmed (Conrad et al., 2012; Shimojo 
et al., 2008).  It has also been reported that Tip60 plays a role in the acetylation of histones H2A 
and H4 (Sapountzi et al., 2006) and is involved in the chromatin remodeling process (Kusch et 
al., 2004).  Due to the involvement with histones, it is likely that Tip60 is also able to interact 
with nucleosomal DNA.  However, further experiments need to be performed to identify whether 
Tip60 can interact with nucleic acids. 
5.2 Drosophila melanogaster Tip60 chromodomain and identified binding partners 
It has been previously reported that the Tip60 chromodomain interacted with H3K4Me1 
(Jeong et al., 2011) and H3K9Me3 (Sun et al., 2009).  Both studies attributed the binding of the 
chromodomain to its substrate resulted in the activation of the HAT domain.  It is still unknown 
how the binding of the chromodomain to its substrates results in acetyltransferase activity.  It is 
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likely that a yet to be determined allosteric mechanism is responsible for HAT activity.  The 
research performed here attempted to elucidate the binding partners for Tip60 chromodomain. 
This study was able to determine that the D. melanogaster Tip60 chromodomain 
interacted predominantly with peptides corresponding to the N-terminal tail sequence of histone 
H4.  The SPR data obtained provided an initial estimate of the strength of the interaction between 
the D. melanogaster Tip60 chromodomain and the H4 tail sequences.  The ITC data obtained 
confirmed that an interaction between the D. melanogaster Tip60 chromodomain and H4 peptide 
occurred.  However, to date, this study has been unable to ascertain, with a high level of 
confidence, specific aspects of the binding event, such as the strength and stoichiometry of the 
interaction due to complications with the chosen methods. 
The SPR experiments had issues with the non-specific binding of the histone tail peptides 
to the surface of the sensor chip.  This was likely due to the positive charge present on the histone 
tail peptides and the highly negative charge of the sensor chip surface, which resulted in an 
interaction between the two.  However, even with non-specific binding issues, it was found that 
the Tip60 chromodomain interacted with the H4 tail peptides.  The rationale behind this notion 
was that several of the peptides used for SPR were identical in sequence and charge, with the 
only difference occurring at the type and location of the modification, yet, each peptide exhibited 
a different signal.  While this indicated the Tip60 chromodomain preferentially interacted with 
the H4 tail peptides, it was only able to give an approximation of the strength of this interaction.  
The reason KD can only be approximated by the SPR experiment is due to the limitations of SPR 
itself.  In an SPR experiment, it is assumed that, when the protein is immobilized to the sensor 
chip surface, all protein molecules are active and in the correct orientation for binding.  Therefore, 
it was necessary to perform a secondary binding assay to confirm the interaction between the H4 
tail peptides and the Tip60 chromodomain. 
To verify the interaction between the Tip60 chromodomain and the H4 peptides, 
isothermal titration calorimetry was selected as a secondary in vitro binding assay.  The benefits 
of using ITC to verify the interaction were that the reaction occurs in solution, therefore 
alleviating non-specific binding issues encountered in SPR or changes to the protein caused by 
immobilization to a sensor chip (Doyle, 1999).  The ITC experiments utilized the titration of the 
H4 peptide into a reaction cell containing the Tip60 chromodomain in solution.  Typically, the 
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gradual titration of the ligand into the reaction cell containing the protein is able to saturate the 
binding sites found on the protein.  However, careful consideration must be made to the volume 
of ligand being injected throughout the experiment, as the saturation of the binding site is 
dependent on the molar ratio of the ligand to protein.  Additionally, to control the molar ratio the 
concentrations of both the ligand and protein must be precisely known.  Even with these 
considerations, it was found that the Tip60 chromodomain could not be saturated.  Due to this 
inability to saturate the protein, an accurate measurement of the KD and stoichiometry could not 
be taken.  To solve these issues, the ITC experiment requires further optimization which will 
include varying the temperature of the reaction, the stir speed, and the volume and number of 
injections used.  If these optimization steps fail to resolve the saturation issue, a homolog of the 
D. melanogaster Tip60 chromodomain may need to be utilized instead.  To date the ITC study 
has only examined the interaction between the D. melanogaster Tip60 chromodomain and the 
unmodified H413-20 peptide.  An interaction between the Tip60 chromodomain and the 
unmodified H413-20 peptide was confirmed to occur, however, the strength and stoichiometry of 
the reaction is yet to be determined. 
It is known that the full length Tip60 protein acetylates histones H2AK5, H3K14, H4K5, 
H4K8, H4K12, and H4K16 (Sapountzi et al., 2006).  Based on the data from the binding 
experiments, it was found that the Tip60 chromodomain interacted with the H4 tail peptides.  The 
binding data suggested that the Tip60 chromodomain preferentially bound H4K20Me1 and 
exhibited weaker interactions with the unmodified H4 peptide, H4K12Ac, H4K16Ac, and 
H4K20Me3.  The H4K20Me1 mark has been found to be associated with transcriptional activation 
(Wang et al., 2008b).  Furthermore, it has been found that specific histone modifications serve to 
recruit and activate the enzymatic activity of specific proteins (Kouzarides, 2007).  The 
preferential binding of the Tip60 chromodomain to H4K20Me1 would be consistent with this 
notion, as it is possible that the binding of the chromodomain could activate the HAT activity of 
the full length Tip60 protein.  However, from the crystal structure, it is still unknown which 
potential binding site is responsible for the targeting and binding of substrates.  One possibility 
that has yet to be explored, is the potential for the Tip60 chromodomain and HAT domain to 
cooperatively bind methyllysine. 
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5.3 Future Directions 
The research to date has revealed a high resolution crystal structure of the D. 
melanogaster Tip60 chromodomain, which has been solved to 1.59 Å.  The crystal structure 
revealed the mechanism previously thought to bind histone tails to be incorrect.  The residues 
thought to be involved in the formation of an aromatic cage for methyllysine binding were found 
to not be close enough to one another to form this structure.  Instead, it was found that the 
chromodomain possessed two distinct potential binding sites for methyllysine.  The first potential 
binding site was composed of residues Trp39 and Tyr 77 and the second potential site was 
composed of residues Tyr60 and Phe63.  The crystal structure also identified a highly conserved 
His-Asp pair which may play a role in contacting the phosphodiester backbone of duplex DNA.  
The research had also identified the binding partners of the D. melanogaster Tip60 
chromodomain.  Through SPR and ITC, it was found that the chromodomain preferentially bound 
the histone H4 tail sequence between residues 13 – 20.  However, the binding data to date has 
not been able to ascertain the strength and stoichiometry of the interaction. 
In the future, this research will need to conclusively determine the strength and 
stoichiometry of the interaction between the H4 peptide and the Tip60 chromodomain.  This will 
be accomplished through further optimization of the SPR and ITC studies already conducted.  
The future of this research still requires that the structural basis of binding be identified.  To do 
this, co-crystallization trials will need to be restarted using short peptide sequences derived from 
the histone H4 N-terminal tail sequences.  Additionally, mutation studies on the residues 
suspected to be involved with binding will need to be done.  Once a residue has been mutated, 
the SPR and ITC experiments need to be repeated with the mutant chromodomain to assess the 
effect of the mutation on binding.  It would also be interesting to determine whether the Tip60 
chromodomain has nucleotide binding capabilities.  To accomplish this, SPR and ITC 
experiments could be performed using short double stranded DNA and the wild type 
chromodomain.  Finally, the research aims to elucidate the mechanism for how the 
chromodomain binding to its partners is able to allosterically regulate the HAT activity of the full 
length Tip60. 
 
102 
 
6 REFERENCES 
Adams, P.D., Afonine, P.V., Bunkoczi, G., Chen, V.B., Davis, I.W., Echols, N., Headd, J.J., 
Hung, L.W., Kapral, G.J., Grosse-Kunstleve, R.W., et al. (2010). PHENIX: a comprehensive 
Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. 
Crystallogr. 66, 213-221. 
Andrews, A.J., and Luger, K. (2011). Nucleosome structure(s) and stability: variations on a 
theme. Annu Rev Biophys 40, 99-117. 
Avvakumov, N., and Cote, J. (2007). The MYST family of histone acetyltransferases and their 
intimate links to cancer. Oncogene 26, 5395-5407. 
Bannister, A.J., and Kouzarides, T. (2011). Regulation of chromatin by histone modifications. 
Cell Res. 21, 381-395. 
Barski, A., Cuddapah, S., Cui, K., Roh, T.Y., Schones, D.E., Wang, Z., Wei, G., Chepelev, I., 
and Zhao, K. (2007). High-resolution profiling of histone methylations in the human genome. 
Cell 129, 823-837. 
Berndsen, C.E., Albaugh, B.N., Tan, S., and Denu, J.M. (2007). Catalytic Mechanism of a MYST 
Family Histone Acetyltransferase. Biochemistry 46, 623-629. 
Berndsen, C.E., and Denu, J.M. (2008). Catalysis and substrate selection by histone/protein lysine 
acetyltransferases. Curr. Opin. Struct. Biol. 18, 682-689. 
Blus, B.J., Wiggins, K., and Khorasanizadeh, S. (2011). Epigenetic virtues of chromodomains. 
Crit. Rev. Biochem. Mol. Biol. 46, 507-526. 
Bosshard, H.R., Marti, D.N., and Jelesarov, I. (2004). Protein stabilization by salt bridges: 
concepts, experimental approaches and clarification of some misunderstandings. J. Mol. 
Recognit. 17, 1-16. 
Campos, E.I., and Reinberg, D. (2009). Histones: annotating chromatin. Annu. Rev. Genet. 43, 
559-599. 
Carrozza, M.J., Utley, R.T., Workman, J.L., and Côté, J. (2003). The diverse functions of histone 
acetyltransferase complexes. Trends Genet. 19, 321-329. 
103 
 
Chan, H.-M., and La Thangue, N.B. (2001). p300/CBP proteins: HATs for transcriptional bridges 
and scaffolds. J. Cell Sci. 114, 2363-2373. 
Conrad, T., Cavalli, F.M., Holz, H., Hallacli, E., Kind, J., Ilik, I., Vaquerizas, J.M., Luscombe, 
N.M., and Akhtar, A. (2012). The MOF chromobarrel domain controls genome-wide H4K16 
acetylation and spreading of the MSL complex. Dev. Cell 22, 610-624. 
Cordingley, M.G., Callahan, P.L., Sardana, V.V., Garsky, V.M., and Colonno, R.J. (1990). 
Substrate Requirements of Human Rhinovirus 3C Protease for Peptide Cleavage in vitro. J. Biol. 
Chem. 265, 9062-9065. 
Cosgrove, M.S., Boeke, J.D., and Wolberger, C. (2004). Regulated nucleosome mobility and the 
histone code. Nat. Struct. Mol. Biol. 11, 1037-1043. 
Davey, C.A., Sargent, D.F., Luger, K., Maeder, A.W., and Richmond, T.J. (2002). Solvent 
Mediated Interactions in the Structure of the Nucleosome Core Particle at 1.9Å Resolution. J. 
Mol. Biol. 319, 1097-1113. 
Davis, T.M., and Wilson, W.D. (2000). Determination of the refractive index increments of small 
molecules for correction of surface plasmon resonance data. Anal. Biochem. 284, 348-353. 
Delvecchio, M., Gaucher, J., Aguilar-Gurrieri, C., Ortega, E., and Panne, D. (2013). Structure of 
the p300 catalytic core and implications for chromatin targeting and HAT regulation. Nat. Struct. 
Mol. Biol. 20, 1040-1046. 
Doyle, M.L. (1999). Titration Microcalorimetry. In Current Protocols in Protein Science (John 
Wiley & Sons, Inc.), pp. 20.24.21-20.24.24. 
Doyon, Y., and Cote, J. (2004). The highly conserved and multifunctional NuA4 HAT complex. 
Curr. Opin. Genet. Dev. 14, 147-154. 
Doyon, Y., Selleck, W., Lane, W.S., Tan, S., and Cote, J. (2004). Structural and Functional 
Conservation of the NuA4 Histone Acetyltransferase Complex from Yeast to Humans. Mol. Cell. 
Biol. 24, 1884-1896. 
Emsley, P., Lohkamp, B., Scott, W.G., and Cowtan, K. (2010). Features and development of 
Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486-501. 
104 
 
Fischle, W. (2009). Tip60-ing the balance in DSB repair. Nat. Cell Biol. 11, 1279-1281. 
Freitas, M.A., Sklenar, A.R., and Parthun, M.R. (2004). Application of mass spectrometry to the 
identification and quantification of histone post-translational modifications. J. Cell. Biochem. 92, 
691-700. 
Gavaravarapu, S., and Kamine, J. (2000). Tip60 inhibits activation of CREB protein by protein 
kinase A. Biochem. Biophys. Res. Commun. 269, 758-766. 
Ginsburg, D.S., Anlembom, T.E., Wang, J., Patel, S.R., Li, B., and Hinnebusch, A.G. (2014). 
NuA4 links methylation of histone H3 lysines 4 and 36 to acetylation of histones H4 and H3. J. 
Biol. Chem. 289, 32656-32670. 
Ginsburg, D.S., Govind, C.K., and Hinnebusch, A.G. (2009). NuA4 lysine acetyltransferase Esa1 
is targeted to coding regions and stimulates transcription elongation with Gcn5. Mol. Cell. Biol. 
29, 6473-6487. 
Goujon, M., McWilliam, H., Li, W., Valentin, F., Squizzato, S., Paern, J., and Lopez, R. (2010). 
A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res. 38, W695-
699. 
Hodawadekar, S.C., and Marmorstein, R. (2007). Chemistry of acetyl transfer by histone 
modifying enzymes: structure, mechanism and implications for effector design. Oncogene 26, 
5528-5540. 
Hughes, R.M., Wiggins, K.R., Khorasanizadeh, S., and Waters, M.L. (2007). Recognition of 
trimethyllysine by a chromodomain is not driven by the hydrophobic effect. Proc. Natl. Acad. 
Sci. U. S. A. 104, 11184-11188. 
Ikura, T., Ogryzko, V.V., Grigoriev, M., Groisman, R., Wang, J., Horikoshi, M., Scully, R., Qin, 
J., and Nakatani, Y. (2000). Involvement of the TIP60 Histone Acetylase Complex in DNA 
Repair and Apoptosis. Cell 102, 463-473. 
Jeong, K.W., Kim, K., Situ, A.J., Ulmer, T.S., An, W., and Stallcup, M.R. (2011). Recognition 
of enhancer element-specific histone methylation by TIP60 in transcriptional activation. Nat. 
Struct. Mol. Biol. 18, 1358-1365. 
105 
 
Kalkhoven, E. (2004). CBP and p300: HATs for different occasions. Biochem. Pharmacol. 68, 
1145-1155. 
Kamine, J., Elangovan, B., Subramanian, T., Coleman, D., and Chinnadurai, G. (1996). 
Identification of a Cellular Protein That Specifically Interacts with the Essential Cysteine Region 
of the HIV-1 Tat Transactivator. Virology 216, 357-366. 
Kim, C.H., Kim, J.W., Jang, S.M., An, J.H., Song, K.H., and Choi, K.H. (2012). Transcriptional 
activity of paired homeobox Pax6 is enhanced by histone acetyltransferase Tip60 during mouse 
retina development. Biochem. Biophys. Res. Commun. 424, 427-432. 
Kim, D., Blus, B.J., Chandra, V., Huang, P., Rastinejad, F., and Khorasanizadeh, S. (2010). 
Corecognition of DNA and a methylated histone tail by the MSL3 chromodomain. Nat. Struct. 
Mol. Biol. 17, 1027-1029. 
Kouzarides, T. (2007). Chromatin modifications and their function. Cell 128, 693-705. 
Krissinel, E., and Henrick, K. (2004). Secondary-structure matching (SSM), a new tool for fast 
protein structure alignment in three dimensions. Acta Crystallogr. D Biol. Crystallogr. 60, 2256-
2268. 
Kusch, T., Florens, L., Macdonald, W.H., Swanson, S.K., Glaser, R.L., Yates, J.R., Abmayr, 
S.M., Washburn, M.P., and Workman, J.L. (2004). Acetylation by Tip60 is required for selective 
histone variant exchange at DNA lesions. Science 306, 2084-2087. 
Kusch, T., Mei, A., and Nguyen, C. (2014). Histone H3 lysine 4 trimethylation regulates 
cotranscriptional H2A variant exchange by Tip60 complexes to maximize gene expression. Proc. 
Natl. Acad. Sci. U. S. A. 111, 4850-4855. 
Lee, K.K., and Workman, J.L. (2007). Histone acetyltransferase complexes: one size doesn't fit 
all. Nat. Rev. Mol. Cell Biol. 8, 284-295. 
Legube, G., and Trouche, D. (2003). Identification of a larger form of the histone acetyl 
transferase Tip60. Gene 310, 161-168. 
Li, G., and Reinberg, D. (2011). Chromatin higher-order structures and gene regulation. Curr. 
Opin. Genet. Dev. 21, 175-186. 
106 
 
Liu, X., Wang, L., Zhao, K., Thompson, P.R., Hwang, Y., Marmorstein, R., and Cole, P.A. 
(2008). The structural basis of protein acetylation by the p300/CBP transcriptional coactivator. 
Nature 451, 846-850. 
Luger, K., Dechassa, M.L., and Tremethick, D.J. (2012). New insights into nucleosome and 
chromatin structure: an ordered state or a disordered affair? Nat. Rev. Mol. Cell Biol. 13, 436-
447. 
Luger, K., and Hansen, J.C. (2005). Nucleosome and chromatin fiber dynamics. Curr. Opin. 
Struct. Biol. 15, 188-196. 
Luger, K., Mäder, A.W., Richmond, R.K., Sargent, D.F., and Richmond, T.J. (1997). Crystal 
structure of the nucleosome core particle at 2.8 Å resolution. Nature 389, 251-260. 
Ma, J.C., and Dougherty, D.A. (1997). The Cation−π Interaction. Chem. Rev. 97, 1303-1324. 
Marmorstein, R. (2001). Protein modules that manipulate histone tails for chromatin regulation. 
Nature Reviews Molecular Cell Biology 2, 422-432. 
Marmorstein, R., and Roth, S.Y. (2001). Histone acetyltransferases: function, structure, and 
catalysis. Curr. Opin. Genet. Dev. 11, 155-161. 
Marmorstein, R., and Trievel, R.C. (2009). Histone modifying enzymes: Structures, mechanisms, 
and specificities. Biochim. Biophys. Acta 1789, 58-68. 
Maze, I., Noh, K.M., Soshnev, A.A., and Allis, C.D. (2014). Every amino acid matters: essential 
contributions of histone variants to mammalian development and disease. Nat. Rev. Genet. 15, 
259-271. 
McCoy, A.J., Grosse-Kunstleve, R.W., Adams, P.D., Winn, M.D., Storoni, L.C., and Read, R.J. 
(2007). Phaser crystallographic software. J Appl Crystallogr 40, 658-674. 
McGinty, R.K., and Tan, S. (2015). Nucleosome structure and function. Chem. Rev. 115, 2255-
2273. 
Musselman, C.A., Lalonde, M.E., Cote, J., and Kutateladze, T.G. (2012). Perceiving the 
epigenetic landscape through histone readers. Nat. Struct. Mol. Biol. 19, 1218-1227. 
107 
 
Nielsen, P.R., Nietlispach, D., Buscaino, A., Warner, R.J., Akhtar, A., Murzin, A.G., Murzina, 
N.V., and Laue, E.D. (2005). Structure of the chromo barrel domain from the MOF 
acetyltransferase. J. Biol. Chem. 280, 32326-32331. 
Nielsen, P.R., Nietlispach, D., Mott, H.R., Callaghan, J., Bannister, A., Kouzarides, T., Murzin, 
A.G., Murzina, N.V., and Laue, E.D. (2002). Structure of the HP1 chromodomain bound to 
histone H3 methylated lysine 9. Nature 416, 103-107. 
Otwinowski, Z., and Minor, W. (1997). Processing of X-ray Diffraction Data Collected in 
Oscillation Mode. In Volume 276: Macromolecular Crystallography, Part A, J. Carter, C.W., and 
R.M. Sweet, eds. (New York: Academic Press), pp. 307-326. 
Peng, L., Ling, H., Yuan, Z., Fang, B., Bloom, G., Fukasawa, K., Koomen, J., Chen, J., Lane, 
W.S., and Seto, E. (2012). SIRT1 negatively regulates the activities, functions, and protein levels 
of hMOF and TIP60. Mol. Cell. Biol. 32, 2823-2836. 
Pirooznia, S.K., Sarthi, J., Johnson, A.A., Toth, M.S., Chiu, K., Koduri, S., and Elefant, F. (2012). 
Tip60 HAT activity mediates APP induced lethality and apoptotic cell death in the CNS of a 
Drosophila Alzheimer's disease model. PLoS One 7, e41776. 
Robert, X., and Gouet, P. (2014). Deciphering key features in protein structures with the new 
ENDscript server. Nucleic Acids Res. 42, W320-324. 
Roth, S.Y., Denu, J.M., and Allis, C.D. (2001). Histone Acetyltransferases. Annu. Rev. Biochem. 
70, 81-120. 
Ruthenburg, A.J., Li, H., Patel, D.J., and Allis, C.D. (2007). Multivalent engagement of 
chromatin modifications by linked binding modules. Nat. Rev. Mol. Cell Biol. 8, 983-994. 
Sapountzi, V., and Cote, J. (2011). MYST-family histone acetyltransferases: beyond chromatin. 
Cell. Mol. Life Sci. 68, 1147-1156. 
Sapountzi, V., Logan, I.R., and Robson, C.N. (2006). Cellular functions of TIP60. Int. J. 
Biochem. Cell Biol. 38, 1496-1509. 
Segal, E., and Widom, J. (2009). What controls nucleosome positions? Trends Genet. 25, 335-
343. 
108 
 
Shimojo, H., Sano, N., Moriwaki, Y., Okuda, M., Horikoshi, M., and Nishimura, Y. (2008). 
Novel structural and functional mode of a knot essential for RNA binding activity of the Esa1 
presumed chromodomain. J. Mol. Biol. 378, 987-1001. 
Sievers, F., Wilm, A., Dineen, D., Gibson, T.J., Karplus, K., Li, W., Lopez, R., McWilliam, H., 
Remmert, M., Soding, J., et al. (2011). Fast, scalable generation of high-quality protein multiple 
sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539. 
Soria, G., Polo, S.E., and Almouzni, G. (2012). Prime, repair, restore: the active role of chromatin 
in the DNA damage response. Mol. Cell 46, 722-734. 
Squatrito, M., Gorrini, C., and Amati, B. (2006). Tip60 in DNA damage response and growth 
control: many tricks in one HAT. Trends Cell Biol. 16, 433-442. 
Srivastava, P., Khandokar, Y.B., Swarbrick, C.M., Roman, N., Himiari, Z., Sarker, S., Raidal, 
S.R., and Forwood, J.K. (2014). Structural characterization of a Gcn5-related N-acetyltransferase 
from Staphylococcus aureus. PLoS One 9, e102348. 
Struhl, K., and Segal, E. (2013). Determinants of nucleosome positioning. Nat. Struct. Mol. Biol. 
20, 267-273. 
Suganuma, T., and Workman, J.L. (2011). Signals and Combinatorial Functions of Histone 
Modifications. Annu. Rev. Biochem. 80, 473-499. 
Sun, Y., Jiang, X., Chen, S., Fernandes, N., and Price, B.D. (2005). A role for the Tip60 histone 
acetyltransferase in the acetylation and activation of ATM. Proc. Natl. Acad. Sci. U. S. A. 102, 
13182-13187. 
Sun, Y., Jiang, X., and Price, B.D. (2010). Tip60: connecting chromatin to DNA damage 
signaling. Cell Cycle 9, 930-936. 
Sun, Y., Jiang, X., Xu, Y., Ayrapetov, M.K., Moreau, L.A., Whetstine, J.R., and Price, B.D. 
(2009). Histone H3 methylation links DNA damage detection to activation of the tumour 
suppressor Tip60. Nat. Cell Biol. 11, 1376-1382. 
Tang, Y., Luo, J., Zhang, W., and Gu, W. (2006). Tip60-dependent acetylation of p53 modulates 
the decision between cell-cycle arrest and apoptosis. Mol. Cell 24, 827-839. 
109 
 
Taverna, S.D., Li, H., Ruthenburg, A.J., Allis, C.D., and Patel, D.J. (2007). How chromatin-
binding modules interpret histone modifications: lessons from professional pocket pickers. Nat. 
Struct. Mol. Biol. 14, 1025-1040. 
Tremethick, D.J. (2007). Higher-order structures of chromatin: the elusive 30 nm fiber. Cell 128, 
651-654. 
Tropberger, P., and Schneider, R. (2013). Scratching the (lateral) surface of chromatin regulation 
by histone modifications. Nat. Struct. Mol. Biol. 20, 657-661. 
Turnbull, W.B., and Daranas, A.H. (2003). On the value of c: can low affinity systems be studied 
by isothermal titration calorimetry? J. Am. Chem. Soc. 125, 14859-14866. 
Utley, R.T., and Cote, J. (2003). The MYST Family of Histone Acetyltransferases. In Protein 
Complexes that Modify Chromatin, J.L. Workman, ed. (Springer Berlin Heidelberg), pp. 203-
236. 
van Attikum, H., and Gasser, S.M. (2009). Crosstalk between histone modifications during the 
DNA damage response. Trends Cell Biol. 19, 207-217. 
Veloso, A., Kirkconnell, K.S., Magnuson, B., Biewen, B., Paulsen, M.T., Wilson, T.E., and 
Ljungman, M. (2014). Rate of elongation by RNA polymerase II is associated with specific gene 
features and epigenetic modifications. Genome Res. 24, 896-905. 
Venkatesh, S., and Workman, J.L. (2015). Histone exchange, chromatin structure and the 
regulation of transcription. Nat. Rev. Mol. Cell Biol. 16, 178-189. 
Vetting, M.W., LP, S.d.C., Yu, M., Hegde, S.S., Magnet, S., Roderick, S.L., and Blanchard, J.S. 
(2005). Structure and functions of the GNAT superfamily of acetyltransferases. Arch. Biochem. 
Biophys. 433, 212-226. 
Walker, P.A., Leong, L.E.-C., Ng, P.W.P., Tan, S.H., Waller, S., Murphy, D., and Porter, A.G. 
(1994). Efficient and Rapid Affinity Purification of Proteins Using Recombinant Fusion 
Proteases. Nat. Biotechnol. 12, 601-605. 
110 
 
Wang, L., Tang, Y., Cole, P.A., and Marmorstein, R. (2008a). Structure and chemistry of the 
p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase 
evolution and function. Curr. Opin. Struct. Biol. 18, 741-747. 
Wang, Z., Zang, C., Rosenfeld, J.A., Schones, D.E., Barski, A., Cuddapah, S., Cui, K., Roh, T.Y., 
Peng, W., Zhang, M.Q., et al. (2008b). Combinatorial patterns of histone acetylations and 
methylations in the human genome. Nat. Genet. 40, 897-903. 
Winn, M.D., Ballard, C.C., Cowtan, K.D., Dodson, E.J., Emsley, P., Evans, P.R., Keegan, R.M., 
Krissinel, E.B., Leslie, A.G., McCoy, A., et al. (2011). Overview of the CCP4 suite and current 
developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235-242. 
Wolf, E., Vassilev, A., Makino, Y., Sali, A., Nakatani, Y., and Burley, S.K. (1998). Crystal 
Structure of a GCN5-Related N-acetyltransferase: Serratia marcescens Aminoglycoside 3-N-
acetyltransferase. Cell Cycle 94, 439-449. 
Xiao, H., Chung, J., Kao, H.Y., and Yang, Y.C. (2003). Tip60 is a co-repressor for STAT3. J. 
Biol. Chem. 278, 11197-11204. 
Yan, Y., Barlev, N.A., Haley, R.H., Berger, S.L., and Marmorstein, R. (2000). Crystal Structure 
of Yeast Esa1 Suggests a Unified Mechanism for Catalysis and Substrate Binding by Histone 
Acetyltransferases. Mol. Cell 6, 1195-1205. 
Yan, Y., Harper, S., Speicher, D.W., and Marmorstein, R. (2002). The catalytic mechanism of 
the ESA1 histone acetyltransferase involves a self-acetylated intermediate. Nat. Struct. Biol. 9, 
862-869. 
Yang, C., Wu, J., and Zheng, Y.G. (2012). Function of the active site lysine autoacetylation in 
Tip60 catalysis. PLoS One 7, e32886. 
Yang, X. (2004). The diverse superfamily of lysine acetyltransferases and their roles in leukemia 
and other diseases. Nucleic Acids Res. 32, 959-976. 
Yap, K.L., and Zhou, M.M. (2011). Structure and mechanisms of lysine methylation recognition 
by the chromodomain in gene transcription. Biochemistry 50, 1966-1980. 
111 
 
Yuan, H., Rossetto, D., Mellert, H., Dang, W., Srinivasan, M., Johnson, J., Hodawadekar, S., 
Ding, E.C., Speicher, K., Abshiru, N., et al. (2012). MYST protein acetyltransferase activity 
requires active site lysine autoacetylation. EMBO J. 31, 58-70. 
Zentner, G.E., and Henikoff, S. (2013). Regulation of nucleosome dynamics by histone 
modifications. Nat. Struct. Mol. Biol. 20, 259-266. 
 
